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The innate immune system represents the host’s initial defence mechanism which responds to 
a diverse range of antigenic stimuli. This response is characterised by the activation of pathogen 
recognition receptors upon recognition of microbial patterns. This action results in the 
activation of the transcription factor NF-κB, MAPK signalling pathways and the induction of 
pro-inflammatory cytokines. The gastrointestinal mucus layer serves as an essential innate 
barrier to pathogenic adhesion and subsequent infection. Dysregulation in the integrity or 
function of the mucosal layer has been implicated in malabsorption, leading to reduced animal 
productivity. The objective of the work described in this thesis was to evaluate the effect of 
dietary supplementation of mannan-rich natural formulations on broiler tissue morphology, 
mucin barrier integrity, digestive enzyme capacity, apoptotic and necroptotic cell death levels 
and the expression of inflammatory cytokines. Supplementation of diet with each mannan-rich 
fraction (MRF) increased villus height and villus surface area. In addition, crypt depth was 
increased upon dietary inclusion of naturally-derived additives. Dietary inclusion of mannan-
rich fraction (MRF) supplements (supplements 1 to 3) enhanced goblet cell density and mucus 
layer thickness. Incorporation of mannan-rich fraction 1 (MRF-1) and mannan-rich fraction 2 
(MRF-2) enhanced the activities of digestive enzymes maltase, sucrase and alkaline 
phosphatase. The expression of apoptotic cell death markers (TUNEL staining and caspase-3 
expression) was not altered statistically upon incorporation of dietary additives. Receptor-
interacting serine/threonine kinase 3 (RIPK3) expression was significantly decreased upon 
MRF-1 supplementation in the duodenum, jejunum and caecum. Supplementation of mannan-
rich fraction 3 (MRF-3) significantly enhanced protein expression levels of p-Akt. MRF-2 and 
MRF-3 dietary incorporation led to a significant decrease in RIPK3 protein expression levels.  
Dietary additive inclusion had little effect on serum and tissue lysate expression of 
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inflammatory cytokines. The work in this thesis demonstrates a role for mannan-rich fractions 
in improving broiler tissue morphology, barrier integrity and digestive enzyme capacity, thus 
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1.1 Role of Dietary Formulation additives in the poultry industry 
1.1.1 Overview of poultry industry  
 
Poultry production has increased exponentially within the past half-century, to meet the 
demands of an ever-growing population. In 2014, poultry meat production totalled over 13 
million tonnes in the European Union, representing almost a 10% increase from 2007 
(Eurostat). Within the past 50 years, significant improvements have been made in poultry 
production technologies. This has resulted in drastically reduced mortality rates, enhanced 
weight gain - with birds almost five times larger compared to broilers bred in 1957-  and 
improvements in feed conversion ratios (the ratio at which feed input results in overall weight 
gain) from 3.26 in 1957, to 2.68 in 2001 (Havenstein et al., 2003). A ‘broiler’ is the term 
attributed to any chicken that has been bred specifically for the purpose of poultry meat 
production (Le Bihan-Duval et al., 1999) Progressions in broiler chicken diet strategies have 
also led to improvements in body weight and growth performance. Antibiotic use in broiler 
production commenced in the mid-20th century (Castanon, 2007). The inclusion of 
antimicrobial growth promoters (AGP) in broiler feed had led to significant improvements in 
animal growth and performance (Castanon, 2007). The supplementation of animal feed with 
antibiotics at sub-therapeutic levels greatly alleviated pathogen invasion and broiler mortality 
rates (Miles et al., 2006). Several mechanisms have been postulated for how antibiotic 
supplementation could improve broiler intestinal health and growth including: reducing the 
colonisation levels of pathogenic bacteria such as E. coli and S. aureus and the enhancement 
of animal production through increased nutrient absorption, alterations of the composition of 
intestinal microflora and intestinal physiology (Niewold, 2007; Schlundt and Aarestrup, 2017).  
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1.1.2 Decline of antibiotics 
 
The addition of antibiotics at a sub-therapeutic level in animal feed has resulted in the formation 
of a favourable environment for the onset of microbial antibiotic resistance (Roto et al., 2015). 
Resistant bacteria have the potential to be transferred from animal to human at several phases 
of animal processing, such as during the slaughtering or processing stages (Verraes et al., 
2013). Mounting public concern regarding the risk posed by antimicrobial resistance led to the 
outright ban of the use of antibiotics in poultry production in the European Union (EPC, 2005). 
There has been a plethora of conflicting evidence regarding the effects of the ban on AGPs. 
The sharpest effect of the ban was felt in the pork industry, most notably in piglets (Casewell 
et al., 2003; Hao et al., 2014; Schlundt and Aarestrup, 2017). Incidences of disease rapidly 
increased shortly after the ban and animal mortality increased. Animal diseases such as necrotic 
enteritis again gained prominence following the ban on antibiotic growth promoters (Tsiouris 
et al., 2016). Necrotic enteritis is a primary concern in the poultry industry due to the high 
mortality rates and decreased production associated with the disease (Timbermont et al., 2011). 
The sub-clinical form of this disease is considered to be of higher risk as symptoms are not 
apparent and the disease can progress undetected, resulting in greater economic losses (Dahiya 
et al., 2006). Broilers infected with necrotic enteritis have a reduced ability to digest and absorb 
available nutrients, resulting in lower feed conversion ratios and reduced weight gain (Paiva 
and McElroy, 2014). The negative effects of the ban of AGPs have led to renewed focus on the 
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1.1.3 Alternatives for Antibiotics  
 
Several approaches to enhance broiler health and growth involve the use of biologics 
incorporated into animal feed either alone or in combination. The most well-defined 
alternatives include: in-feed enzymes, prebiotics, direct-fed microbials, β-glucans and 
mannanoligosaccharides. 
1.1.3.1 In-feed Enzymes 
In-feed enzymes have long been used in animal nutrition. There are several different types of 
in-feed enzymes utilised in the animal feed industry. One such type of enzymes are microbial 
phytases, which break down phytate to release residual phosphorous (Ravindran, 2013). 
Phosphorous has been shown to be essential for broiler growth and maintenance in addition to 
tissue repair (Adedokun & Adeola, 2013). The majority of absorption of phosphorous occurs 
in the duodenum and jejunum (Liu et al., 2016). Another popular type of feed enzyme are 
glucanases. Glucanases have been demonstrated to improve boiler performance and the 
absorption of fat, starch and protein (Annison, 1992; Marquardt, Boros, Guenter, & Crow, 
1994). The main goal for the use of in-feed enzymes is to enhance nutrient digestibility, 
however the role of intestinal microbiota in influencing diet is only recently coming to light. 
Evidence has shown that unassimilated nutrients from a high-energy can contribute to intestinal 
microbiota overgrowth and subsequent induction of inflammation, an energy expensive 
process (Pan & Yu, 2014; Wu, Stanley, Rodgers, Swick, & Moore, 2014). The investigation of 
the interplay between intestinal microbiota and influences on diet is an ever-expanding field.  
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Probiotics have been defined as the use of feed products that may be derived from live or 
naturally occurring microorganisms, differing from prebiotics in that prebiotics may also 
contain enzymes or crude extracts (Brashears et al., 2003; McAllister et al., 2011). Probiotics 
have been postulated to convey beneficial effects on poultry through modulation of the immune 
system, the promotion of commensal microbiota growth and the inhibition of pathogenic 
bacteria proliferation in addition to increasing digestive enzyme activity (Dahiya et al., 2006; 
McAllister et al., 2011). A reported role of probiotics is to maintain a healthy balance between 
‘beneficial’ and ‘non-beneficial’ microbiota (Pan & Yu, 2014). Under conditions of stress, 
‘non-beneficial’ bacteria may exponentially proliferate and lead to reduced feed-intake and 
gastroenteritis (Jadhav, Sharma, Katoch, Sharma, & Mane, 2015).   The incorporation of 
probiotics into broiler feed has led to reduced incidences of avian coccidiosis, an important 
finding in the poultry industry due to the effects of increased mortality and reduced feed 
efficiency upon infection of broilers (Brashears et al., 2003). The inclusion of Lactobacillus- 
and Bacillus- based probiotics into animal feed led to two reported benefits: the reduction of 
colonisation levels of enteric pathogens in the gastrointestinal layer and a reported increase in 
the levels of beneficial bacteria in the microbiome (Gebert et al., 2007). Evidence has also 
emerged of probiotic supplementation increasing antibody response levels during an oral 
pathogenic challenge (Brisbin et al., 2008). 
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Prebiotics have been defined as substances that are indigestible to the host but can alter the 
activity and composition of gut microflora to confer a beneficial effect on the host (Gaggia et 
al., 2010; Roberfroid, 2007). Recent evidence has demonstrated the possibility of yeast cell 
wall derivatives regulating innate signalling pathways, including the mitogen-activated protein 
kinase (MAPK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) 
signalling cascades through interactions with essential signalling proteins (Tian et al., 2015). 
Prebiotics have been demonstrated to alter the composition of intestinal microbiota, increasing 
the presence of potentially beneficial microbiota such as bifidobacterial and lactobacilli 
(Gaggia et al., 2010). These bacteria have been shown to modulate the immune response, 
adhere to the gastrointestinal layer and confer a role in the regulation of gut motility 
(Bernardeau et al., 2006; Hamilton-Miller, 2004; Picard et al., 2005). Commonly incorporated 
types of prebiotics in the poultry industry include inulin and fructooligosaccharides (FOS). 
FOS are composed of short chains of fructose while inulin can consist of between 20 and 
several thousand fructose molecules (Hughes et al., 2017)  These prebiotics have been 
demonstrated to select for microorganisms hypothesised to promote nutrient assimilation and 
also to prevent the adhesion and colonisation of potentially pathogenic bacteria (Barko, 
McMichael, Swanson, & Williams, 2017; Ricke, 2015; Roberfroid, 2007).  
Mannan-rich fraction 1 (MRF-1), mannan-rich fraction 2 (MRF-2), and mannan-rich fraction 
3 (MRF-3) (Alltech Inc., Lexington, Kentucky, USA) are naturally-derived dietary 
supplements designed to take account of the growing use of natural alternatives to antibiotic 
growth promoters. These supplements are derived from the cell wall of Saccharomyces 
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cerevisiae and can potentially modulate the immune response, improve intestinal capacity and 
function, as well as enhancing animal performance and growth.  
1.1.3.3.2 Mannanoligosaccharides 
 
Mannanoligosaccharides (MOS) derived from the outer yeast cell wall of S. cerevisiae have 
been hypothesised to improve gastrointestinal health, growth, mortality rates and performance 
of broiler chickens (Xiao et al., 2012). The incorporation of MOS into feed has been reported 
to potentially increase villus length (therefore potentially increasing the surface area available 
for nutrient absorption), increase goblet cell presence (thereby enhancing mucous lining 
protection), alter crypt depth and also cause a decrease in the levels of E. coli and Salmonella 
colonisation (Baurhoo, Letellier, Zhao, & Ruiz-Feria, 2007; Griggs & Jacob, 2005; Sims, 
Dawson, Newman, Spring, & Hoogell, 2004). Several different mechanisms have been 
suggested for the action of MOS in animal health and productivity. Reduced bacterial presence 
due to MOS is hypothesised to be a result of the interaction of MOS with mannose-binding 
lectins on bacterial cell surfaces (D. Kelly, Begbie, & King, 1994). Bacteria containing type-1 
fimbriae, such as E. coli and Salmonella, attach to the intestinal layer though mannose residues 
present in intestinal mucins (Baurhoo et al., 2007). Upon incorporation of MOS into broiler 
diets, enteric pathogens will instead attach to mannose residues present in MOS, resulting in 
their excretion from the animal (Line et al., 1998). This mode of pathogen exclusion greatly 
protects the intestinal layer from pathogenic bacteria and invading toxins while also permitting 
host energy to be utilised for growth, and not the repair and regeneration of the intestinal layer 
(Benites et al., 2008). Immunomodulating effects were observed in broilers fed with MOS such 
as the increased expression of cytokines and genes associated with antioxidant activity such as 
SOD1 and TXN (Xiao et al., 2012). Additionally, it has been reported that MOS-incorporation 
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led to reduced coccidiosis infection in broilers due to improved gut morphology (Elmusharaf, 
Peek, Nollet, & Beynen, 2007).  
 
1.2 Characteristics and composition of the yeast cell wall 
 
1.2.1 Yeast cell wall overview 
 
It is clear that yeast cell wall extracts can regulate intestinal health and disease. The yeast cell 
wall (Fig. 1.1) provides mechanical strength, structural integrity and osmotic protection for 
yeast cells (Levin, 2011). It can account for almost 20% of total cell mass (Aguilar-Uscanga & 
François, 2003). This rigid layer can vary in thickness between 100 and 200nm (Lipke & 
Ovalle, 1998). The yeast cell wall is typically comprised of glucans and mannans, which 
together form an intertwined layer, providing strength and solidity to the cell wall (Erwig and 
Gow, 2016; Kollar et al., 1997). Glucans such as (1→3)-β glucans play an essential role in the 
maintenance of cell wall shape whereas (1→6)-β-D-glucans function as a point of attachment 
for the majority of polysaccharides present on the cell wall (Kwiatkowski et al., 2009; Lowman 
et al., 2011). Mannans present on the outer portion of the yeast cell wall can convey a protective 
effect, prevent the adhesion and infiltration of foreign toxins and pathogens (Erwig and Gow, 
2016). The cell wall is composed of an inner layer (consisting primarily of β1,3- glucan 
molecules) that serves as a scaffold for other proteins and which also protects an outer layer of 
glycoproteins involved in the permeability of the cell wall and cell-cell adhesion events (Levin, 
2011; Luo et al., 2015). 
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Figure 1.1 Overview of the yeast cell wall 
 
1.2.2 Functions of the yeast cell wall 
 
The yeast cell wall (YCW) serves several essential functions: the determination of cellular 
shape, the regulation of cell-cell recognition events, communication with the external 
environment and also the maintenance of internal osmotic homeostasis, which prevents the cell 
bursting in response to alterations in environmental or physiological conditions (Kogan and 
Kocher, 2007; Kollar et al., 1997). The composition of the cell wall provides protection against 
mechanical or physical stress, due to the high elasticity and mechanical strength of the wall 
(Aguilar-Uscanga & François, 2003; Martinez de Marañon, Marechal, & Gervais, 1996). The 
elasticity of the wall is generally attributed to the presence of 1,3-β-glucan molecules, which 
can adopt a helical conformation and exist in varying states of extension (Smits, C Kapteyn, 
van den Ende, & Mklis, 1999). The inner layer also serves as an attachment site for proteins 
that are structural components of the outer layer of the YCW (Klis, Mol, Hellingwerf, & Brul, 
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2002). The cell wall may also function as a scaffold for proteins (Levin, 2011). β1,3- glucan 
molecules are the major constituents of these scaffolds that serve as a site of attachment for 
heavily-glycosylated external proteins that have been implicated in determining the 
permeability of the cell wall (Klis et al., 2002; Levin, 2011; Lipke & Ovalle, 1998). The 
glycoproteins associated with the outer layer of the cell wall thereby serve to protect the cell 
from potentially pathogenic proteins and cell wall-degrading enzymes such as cellulose and 
hemicellulose enzymes (Levin, 2011; Murashima, Kosugi, & Doi, 2003). 
1.2.3 YCW glycoproteins 
 
Two general classes of outer layer glycoproteins exist: glycosylphosphatidylinositol (GPI)- 
modified cell wall proteins (CWPs), which are indirectly linked to β1,3- glucans through β1-6, 
glucan chains and protein with internal repeats (PIR-) CWPs that are directly linked to β1,3- 
glucans (Klis et al., 2002; Yin, de Groot, de Koster, & Klis, 2008). External glycoproteins 
serve numerous essential functions including the maintenance of cell wall integrity by 
crosslinking polysaccharides, facilitating mating and flocculation between cells, iron uptake, 
retention of water, association with epithelial cells and also resistance to oxidative stress (Klis, 
Boorsma, & De Groot, 2006; Levin, 2005, 2011; Yin et al., 2008). GPI-CWPs can be linked to 
the non-reducing end of a β1,6-glucan through the reducing end of a mannose residue (after 
cleavage of the GPI between its GlcN and Man residue) or to a glucose residue on a β1,6- 
glucan chain (Fujii, Shimoi, & Iimura, 1999; Kollár et al., 1997). PIR-CWPs are ester-linked 
directly to β1,3-glucan chains through amino acid side chains present in the repeat portion of 
the protein (Ecker, Deutzmann, Lehle, Mrsa, & Tanner, 2006; Orlean, 2012). 
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1.3 Role of the intestine in maintenance of health in broilers 
 
1.3.1 Gastrointestinal tract overview 
 
The gastrointestinal (GI) (Fig. 1.2) tract absorbs and digests available nutrients and also acts 
as a selective barrier that prevents the entry of potentially pathogenic bacteria with wide-
ranging implications for the overall health and performance of commercial poultry (Yegani & 
Korver, 2008). The components of the avian GI tract include the oesophagus, crop, 
proventriculus, gizzard, small intestine (duodenum, jejunum and ileum) and the large intestine 
(caecum, colon and cloaca) (Yegani & Korver, 2008). The majority of food digestion and 
absorption occurs in the small intestine (Taghipoor, Barles, Georgelin, Licois, & Lescoat, 
2014). The GI tract is composed of  four layers: the mucosa, the submucosa, the muscular layer 
and the adventitial layer (Cheng et al., 2010). The mucosal layer of the small intestine can be 
broadly divided into two fundamental structures: the villi and the crypts (Clevers, 2013) (see 
Figure 1.3). Villi extend from the epithelial layer of the mucosa to allow a greater surface area 
available for nutrient absorption. Each villus contains microvilli that together form a brush-
border to further increase the surface area present for digestive enzyme activity (Crawley, 
Mooseker, & Tyska, 2014). Digestive enzymes (e.g. maltase, sucrase) play an important role 
in nutrient digestibility, intestinal homeostasis and overall bird performance through the 
availability of a higher volume of nutrients (Pinheiro et al., 2004).  The crypts of Lieberkühn 
are essential for the maintenance of immune homeostasis and the self-renewal of cells involved 
in host defence (Guezguez, Paré, Benoit, Basora, & Beaulieu, 2014; Scoville, Sato, He, & Li, 
2008). The epithelial sublayer of the mucosa has been the subject of extensive research 
regarding bacterial-host interactions with implications in immune function (Abreu, 2010; 
Ashida, Ogawa, Kim, Mimuro, & Sasakawa, 2011; Canny, Swidsinski, & McCormick, 2006). 
The GI tract serves as a hospitable environment for many bacterial species but is also a viable 
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target for many enteric pathogenic species, including C. jejuni, E. coli and Clostridium difficile 
(Guerrant, Steiner, Lima, & Bobak, 1999).  
 
Figure 1.2 Overview of broiler digestive tract 
1.3.2 Cell types present in intestinal tract 
 
Many different cell types are present in the intestinal tract (van der Flier & Clevers, 2009). 
Enterocytes function primarily to assist in nutrient absorption (Snoeck et al., 2005). Goblet 
cells along the epithelial lining secrete mucins that protect and lubricate the mucosa 
(Johansson, Sjövall, & Hansson, 2013). The mucosal layer formed by mucins secreted by 
goblet cells acts as a first line of defence from pathogenic bacteria (Petersson et al., 2011). 
Recent evidence has pointed towards a role of mucins in interacting with dendritic cells and T 
regulatory cells to maintain gut homeostasis in addition to acting as a barrier for the diffusion 
of nutrients (De Santis et al., 2015; Petersson et al., 2011). The efficient uptake of available 
nutrients is essential for bird weight gain and subsequently bird performance. Paneth cells are 
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found in the crypts and are essential in maintaining intestinal barrier integrity (therefore 
maintaining the resistance of broilers to pathogenic bacterium invasion) through the action of 
controlled release of defensin lysozymes and tumour necrosis factor (TNF) (Clevers, 2013) 
(see Figure 1.3).  
 
 
Figure 1.3 Overview of the brush border membrane and protective mucus 
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Goblet cells secrete mucin glycoproteins that form a mucus layer. Antimicrobial peptides are 
unable to adhere to the brush border membrane due to the action of the protective mucus layer. 
The function of the mucus layer ensures that energy available from nutrients is utilised for 
productive purposes such as enhancing broiler performance as opposed to combating 
pathogenic infection.  
1.3.2 Role of cell death in maintenance of intestinal homeostasis 
 
Intestinal epithelial cells play an essential role not only in nutrient absorption, but in the 
maintenance of intestinal homeostasis. The protective layer formed by single epithelial cells 
act as a barrier from potentially pathogenic microorganisms which may potentially impact 
broiler performance (Crawley et al., 2014). The efficient regulation of cell death in the 
epithelial layer is essential for immune defence (Negroni, Cucchiara, & Stronati, 2015). 
Dysregulation of intestinal cell death has been associated with the onset of chronic 
inflammation, intestinal tumour development and inflammatory bowel disease (Delgado, 
Grabinger, & Brunner, 2016; Negroni et al., 2015). Excessive epithelial cell death has also 
been linked to breakdowns in gut barrier function, leading to complications such as infectious 
enteritis (Halpern & Denning, 2015). Several different cellular death processes in the intestinal 
epithelium have been described, namely apoptosis, necroptosis and pyroptosis (Delgado et al., 
2016; Halpern & Denning, 2015; Negroni et al., 2015).  
Apoptosis is a caspase-dependant form of cell death, characterised by cell shrinking and a 
condensed nuclear structure, a phenomenon known as pyknosis (Davidovich, Kearney, & 
Martin, 2014). Two major apoptotic pathways have been described in the literature: the 
intrinsic pathway and the extrinsic pathway (Davidovich et al., 2014). The intrinsic pathway is 
characterised by mitochondrial stress as a result of factors such as heat shock or DNA damage. 
These factors trigger the binding of pro-apoptotic proteins BAX and BAD to the outer 
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membrane of the mitochondria in addition to the recruitment of BAK, a pro-apoptotic protein 
residing internally in the mitochondria (Negroni et al., 2015). This action results in the release 
of cytochrome c, which binds to apoptotic protease activating factor -1 and adenosine tri-
phosphate (ATP) (Delgado et al., 2016). This formation binds to pro-caspase-9, forming a 
complex known as an apoptosome which cleaves pro-caspase-9, thereby activating it and in 
turn activating caspase-3 (Dejean, Martinez-Caballero, & Kinnally, 2006). Second 
mitochondria-derived caspases (SMACs) are present as a result of increased mitochondrial 
permeability. SMACs function to bind to inhibitors of apoptosis proteins (IAPs), thereby 
deactivating them and allowing the intrinsic apoptotic pathway to continue (Elmore, 2007). 
Caspase-3 acts as an effector protein to initiate the process of cellular degradation (Davidovich 
et al., 2014).  
The extrinsic pathway of apoptosis is characterised by the interaction between transmembrane 
receptor and extrinsic signals (Elmore, 2007). The binding of Fas or tumour-necrosis factor-α 
(TNF-α) to their respective receptors initiate a cascade of events resulting in the recruitment of 
adaptor proteins FADD (upon binding of Fas ligand to Fas receptor) or TRADD with the 
recruitment of FADD (upon binding of TNF-α ligand to TNF-α receptor) (Elmore, 2007). The 
recruitment of FADD leads to the association of pro-caspase-8, forming a death-inducing 
signalling complex (DISC) and the activation of caspase-8 (Martin & Henry, 2013). These 
actions result in the activation of effector protein caspase-3 and the degradation process 
resulting in the death of the cell. Apoptosis is essential for the maintenance of internal 
homeostasis (Negroni et al., 2015). The apoptotic process is considered an anti-inflammatory 
process, meaning that the process of apoptosis is immunologically silent, in contrast to another 
form of cell death known as necroptosis.  
Necroptosis is a caspase-independent form of cell death involving the receptor interacting 
protein kinase (RIP) family of proteins (Delgado et al., 2016). The necroptotic pathway is 
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similar to the extrinsic apoptotic pathway as the binding of TNF-α and Fas to their respective 
cell surface receptors initiates a series of events resulting in the phosphorylation of RIP1 and 
RIP3, to form a RIP1-RIP3 heterodimer (Pasparakis & Vandenabeele, 2015). This action leads 
to the auto-phosphorylation of RIP3 and facilitates the recruitment of mixed-lineage kinase 
domain-like protein (MLKL) in order to form a necrosome (Zhou & Yuan, 2014). This results 
in the formation of MLKL homo-trimers, leading to the subsequent release of intracellular 
contents (Davidovich et al., 2014). Necroptosis is considered an inflammatory form of cell 
death which can severely impact broiler homeostasis, as a result of the release of danger-
associated molecular patterns (DAMPs) upon plasma membrane permeabilisation (Pasparakis 
& Vandenabeele, 2015). This is similar to another form of cell death known as pyroptosis. 
Pyroptosis is a necrotic, caspase-1 dependant form of cell death (Man, Karki, & Kanneganti, 
2017). The pyroptotic process is characterised by cellular swelling, chromatin condensing and 
the loss of mitochondrial membrane potential (Shimada et al., 2012). In this pathway, 
pathogen-associated molecular patterns (PAMPs) or DAMPs activate their respective stimuli 
which in turn leads to the recruitment of the inflammasome adapter apoptosis-associated speck-
like protein containing a caspase activation and recruitment domain (ASC) and cysteine-
protease caspase-1 (Shimada et al., 2012). This complex is known as an pyroptosome and 
results in the activation of caspase-1 (Fernandes-Alnemri et al., 2007). Cellular death through 
pyroptosis results in the release of DAMP molecules such as ATP, providing a potent signal 
for the induction of a pro-inflammatory response (Fernandes-Alnemri et al., 2007). Pyroptosis 
leads to the subsequent release of IL-1β and IL-18.  
The regulation and characterisation of cell death in the intestinal epithelium is essential due to 
the role the epithelial layer plays in nutrient absorption and host defence. Breakdowns in the 
function or integrity of the epithelial layer though excessive intestinal cell death can result in 
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the onset of inflammatory disorders that impact the vital functions of the epithelium and by 
extension overall broiler gut health. 
 
1.4 Innate immune system overview 
 
1.4.1 Innate immunity and role of pathogen recognition receptors (PRRs) 
 
Innate immunity is the first line of defence against invading pathogens. The innate immune 
system is comprised of several distinct components including physical and biochemical 
barriers such as skin, lactic and fatty acids as well as immune cells such as dendritic cells, 
natural killer cells, monocytes and macrophages (Thaiss et al., 2016). The innate immune 
response has the ability to in turn activate the adaptive immune response. The adaptive immune 
response can recognise specific pathogenic organisms as a result of several evolutionary 
mechanisms, such as clonal selection and hypervariability (Maxwell et al., 2006). This can 
occur in several ways, primarily through the activation of previously immature dendritic cells 
as a result of pathogenic infection (Clark and Kupper, 2005). The recognition of foreign 
pathogen associated molecular patterns (PAMPs) leads to the presentation of microbial 
peptides by major histocompatibility complex II (MHCII) in DCs whilst also inducing 
expression of co-stimulatory molecules like CD80 and CD80 that are essential for activation 
of naïve T-cells (den Haan et al., 2014). Dendritic cells are the only cell subtype that can present 
antigen to both CD4+ and CD8+ T cells (Clark and Kupper, 2005). These antigen-presenting 
cells (APC) migrate to a network of lymph vessels and interact with B cells and T cells in order 
to determine the specific role and effect the adaptive immune response will play in responding 
to a pathogen. Several features of the adaptive immune response can in turn affect the innate 
response. T-regulatory cells (Tregs) have been demonstrated to supress the inflammatory 
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response of the innate immune system (Thaiss et al., 2016). IL-10 has been hypothesised to 
play an essential role in this action (Thaiss et al., 2016). Type-1 helper cells (Th1) can activate 
the innate immune system through several mechanisms, including cell-cell interaction and 
secretion of IFN-γ (Shanker, 2010). The introduction of YCW material and consequent 
recognition of foreign particles by the host leads to an innate immune reaction, characterised 
by the detection of PAMPs by pathogen recognition receptors (PRRs) (Pinto, Barreto-Bergter, 
& Taborda, 2008). Extensively-studied classes of PRRs include Toll-like receptors (TLRs), 
nucleotide oligomerisation domain protein-1 and 2 (NOD-1 and NOD-2) and Dectin proteins 
-1 and -2 (Kumagai & Akira, 2010). NOD-like receptors are cytoplasmic PRRs that recognise 
bacterial fragments, with NOD-1 and NOD-2 among the best defined in literature (Girardin et 
al., 2003). NOD-like receptors are composed of three structural domains: a nucleotide-binding 
domain, an N-terminal caspase activation and recruitment domain (CARD) and a C-terminal 
leucine-rich repeat domain (LRR) (Sukhithasri, Nisha, Biswas, Anil Kumar, & Biswas, 2013). 
Binding of ligand results in a conformational change leading to the downstream translocation 
of NF-κB into the nucleus from the cytosol and transcriptional activation of inflammatory 
genes (Martinon & Tschopp, 2005). TLRs are transmembrane proteins that recognise a wide 
range of non-self components. For example, TLR2 can identify various pathogenic species 
such as lipopolysaccharides (LPS), flagella and viral dsRNA (Calich et al., 2008); (Akira & 
Takeda, 2004). TLR activation induces a conformational change resulting in an immune 
response via the NF-κB pathway or the production of type-1 interferons due to the activation 
of the TRIF-IRF pathway in the case of TLR3 (Akira & Takeda, 2004). TLR4 activation can 
result in the activation of both pathways in addition to the MAPK pathway (Akira & Takeda, 
2004). The adaptor protein MyD88 is critical for all TLRs, with the exception of TLR3 (West, 
Koblansky, & Ghosh, 2006). Ten different chicken TLR members have been identified at 
present (Ruan et al., 2015). TLRs in chickens recognise similar ligands to their mammalian 
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counterparts (Abdul-Cader et al., 2017). Chicken TLR15 is unique to the avian species and 
recognises extracellular proteases (de Zoete et al., 2011). Chicken TLR15 has been found to 
be expressed primarily in the bone marrow and moderately in the small intestine and liver (de 
Zoete et al., 2011). Chicken TLR21 is considered a functional homologue of mammalian TLR9 
(Abdul-Cader et al., 2017). The stimulation of TLR21 in response to 2′-deoxyribo cytidine-
phosphate-guanosine (CpG) results in the activation of NF-κB and the upregulation of pro-
inflammatory genes (Keestra et al., 2010) Dectin proteins recognise yeast cell wall components 
such as β-glucans and induce phagocytosis (Levitz, 2010). This process also results in the 
activation of NF-κB and cytokine induction (Levitz, 2010). 
Components of the YCW have been reported to initiate a feature of the innate response 
mechanism that conveys quite precise immunological protection (Shashidhara and 
Devegowda, 2003). The complement system is composed of serum and membrane-bound 
proteins that act together as a cascade in order to opsonise pathogens and to induce various 
inflammatory responses that result in the maintenance of tissue homeostasis (Merle et al., 
2015). Mannan and β-glucans have been hypothesised to result in the activation of the 
alternative and lectin-mediated complement pathway (Shashidhara and Devegowda, 2003). 
Pathogen-recognition molecules of the lectin pathway include mannose-binding lectin (MBL) 
and collectins which may have binding potential to mannans and β-glucans, respectively. MBL 
pathogen binding results in a conformational change that leads to the recruitment of MBL-
associated serine proteases (MASPs) (Kjaer et al., 2013). This action facilitates the subsequent 
cleavage of complement proteins C4 and C2 and formation of the C3 convertase (C4b2a) 
(Merle et al., 2015). The end results of this cascade is the establishment of a membrane attack 
complex which dysregulates pathogen cellular integrity, leading to cellular apoptosis (Kjaer et 
al., 2013). Complement molecule C3b can also be deposited on the microbial cell wall in order 
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to enhance recognition and eventual phagocytosis of the pathogen by the cells of the innate 
immune system (Merle et al., 2015).  
 
1.5 Potential markers for innate immune response to yeast cell wall introduction 
 
1.5.1 Markers from innate signalling pathways 
 
A wide range of markers exist that can be used to analyse a host’s immune response upon 
recognition of foreign particles. As described above, TLRs play a crucial role in the recognition 
of foreign PAMPs, which makes them good candidates as markers for the activity of the 
immune response. MyD88 is an adaptor protein essential for the action of all TLRs, with the 
exception of TLR3 (Phongsisay, 2015). Activation of MyD88 leads to the recruitment of 
interleukin-1 receptor-associated kinases (IRAK) and the stimulation of a signalling cascade 
resulting in the upregulation of proinflammatory genes through the canonical NF-κB pathway 
(Phongsisay, 2015; Lawrence, 2009). Other potent activators and therefore potential immune 
markers, include the proinflammatory cytokines IL-1β and TNF-α (Lawrence, 2009). Il-1β is 
initially present in an inactive form (pro-IL1β) that is processed by caspase-1 into its mature 
bioactive form (Kesavardhana and Kanneganti, 2017). Activation of IL-1β or TNF-α leads to 
the stimulation of the canonical NF-κB pathway and the upregulation of pro-inflammatory 
cytokines such as IL-1β, IFNβ, IL-6 and IL-12 in a positive feedback loop mechanism (Newton 
& Dixit, 2012). The TRIF-IRF pathway can be activated upon ligand binding to TLR3/4 with 
the resulting signalling cascade leading to the stimulation of IRF3 and chemokines such as 
CXCL10 (Honda & Taniguchi, 2006). Activation of the MAPK cascade results in the 
upregulation of IL-10, TNF, IL-1β and the downregulation of  iNOS and IFN-β (Arthur & Ley, 
2013). It has been demonstrated that IL-18 plays a role in regulating both the innate and 
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acquired immune response through IFN-γ and the activation of the CD134 response pathway 
upon initial stimulation by MyD88 and IRAK-4 (Maxwell et al., 2006).  The role of IL-18, also 
known as IFN-gamma activating factor, in intestinal inflammation has been attributed to 
regulating the action of IL-1β in addition to playing a role in the Th1 response, in synergy with 
IL-12 (Dinarello et al., 2013; Sivakumar et al., 2002). The proteolytic processing of both pro-
IL-18 and pro- IL-1β is dependent on the action of caspase-1 in humans (Kesavardhana and 
Kanneganti, 2017). 
Caspase-1 is converted into its active form as a result of NLR assembly into a multi-protein 
complex known as an inflammasome (Dubois et al., 2016). The activation of the 
inflammasome leads to the processing of pro- caspase-1 which in turn results in the 
upregulation of both IL-18 and IL-1β in mammals (Man and Kanneganti, 2016). This action 
leads to the execution of a form of inflammation-associated cell death known as pyroptosis 
(Man and Kanneganti, 2016). Pyroptosis is a caspase-1 dependent, rapid form of cell death that 
shares features with both apoptosis and necrosis (Fink and Cookson, 2005). Pyroptosis is 
characterised by cellular swelling, dysregulation of the plasma membrane and the release of 
danger-associated molecular patterns (DAMPs) (Kesavardhana and Kanneganti, 2017). 
Apoptosis can be characterised by the presence of cleaved-caspase-3, a critical executioner of 
the apoptotic cycle (Brauchle et al., 2014). Necroptosis, a type of cell death initiated upon the 
induction of an inflammatory response, can be characterised upon the cleavage of receptor-
interacting serine/threonine-protein kinase 3 (RIPK3) (Kim and Pasparakis, 2014). Five PRRs 
have at present been identified to initiate inflammasome assembly upon recognition of their 
respective stimuli: NLRP1, NLRP3, NLRC4, AIM2 and pyrin (Sharma and Kanneganti, 2016). 
These distinct inflammasomes are termed ‘canonical inflammasomes’ as their mode of action 
implicates the incorporation of pro-caspase 1 in mammals (Kesavardhana and Kanneganti, 
2017). The role of inflammasomes in avian species is poorly defined (Ye et al., 2015). In 
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chickens, pro- IL-1β does not contain a cleavage site for caspase -1, suggesting an alternative 
mechanism for IL-1β processing (Bird et al., 2002). Sequence analyses of the NLPR3 gene in 
yellow chicken revealed only 52% homology with mammalian NLRP3 (Bird et al., 2002; Ye 
et al., 2015). The presence and expression of the NLRP3 inflammasome has been recently 
demonstrated in the literature (Ye et al., 2015). The downstream effects of NLRP3 
inflammasome activation are conserved in mammal and avian species (Ye et al., 2015). 
Elevated expression levels of chIL-1β have been reported in response to pathogenic infection 
(Berndt et al., 2007). Chicken IL-18 has been reported to exhibit similar biological activity to 
mammalian IL-18 (Gibson et al., 2014). Caspase-1 has been predicted to cleave the inactive 
form of chIL-18, with a mechanism of action similar to that observed in mammalian species 
(Gibson et al., 2014). 
1.6 Pathogenic infection in broilers 
 
1.6.1 Colonisation in birds 
 
A wide range of enteric pathogens can potentially invade and infect broilers, increasing 
mortality rates and decreasing weight gain and performance (Awad et al., 2017). Examples of 
the most common enteric pathogens include Salmonella, E. coli, and C. jejuni. Enteric 
pathogens preferentially colonise the intestinal tract of birds due to favourable environmental 
conditions (Dasti, Tareen, Lugert, Zautner, & Gross, 2010). The highest levels of colonisation 
occurs in the crypts of the caeca and the small intestine (Beery, Hugdahl, & Doyle, 1988; 
Conlan, Coward, Grant, Maskell, & Gog, 2007). The pathogenesis of Salmonella involves the 
breakdown of the mucosal barrier in the small intestine. The interaction between Salmonella 
and the epithelial layer results in the recruitment of macrophages to the site of infection 
(Henderson et al., 1999). Salmonella bacterium have demonstrated the ability to replicate 
through use of the host’s macrophages (Henderson et al., 1999). In broiler chickens, C. jejuni 
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colonisation generally occurs after 14 days, which corresponds to diminished maternal 
antibody protection (Sahin et al., 2001). C. jejuni O-linked glycosylated flagella are critical in 
successful host colonisation and the release of invasive antigens (Cia) (Dasti et al., 2010; Logan 
et al., 2009). Proteins such as CadF have been implicated in adhesion to host cell and 
stimulation of signalling cascades resulting in internalisation of the bacterium (Dasti et al., 
2010; Young, Davis, & Dirita, 2007). 
Evidence has also emerged of the ability of enteric pathogens to stimulate signalling cascades 
involved in the innate immune response, potentially resulting in the onset of autoimmunity 
(MacCallum, Haddock, & Everest, 2005; Phongsisay, Hara, & Fujimoto, 2015; Samuelson et 
al., 2013). Campylobacter invasive antigens (Cia) are introduced into host cell via a Type III 
Secretion System (T3SS) originating from the flagellum (Neal-McKinney & Konkel, 2012). 
An effector protein, CiaD, has been experimentally shown to be a potent activator of MAPK 
signalling pathway components ERK1/2 and p38 (Neal-McKinney & Konkel, 2012). 
Glycoconjugates present on C. jejuni have been shown to induce the NF-κB pathway (Al-
Sayeqh, Loughlin, Dillon, Mellits, & Connerton, 2010; Phongsisay et al., 2015). C. jejuni can 
initiate the activation of the NF-κB signalling cascade through TLR4 and chicken TLR21 in 
intestinal epithelial cells leading to the secretion of IL-8 (Al-Sayeqh et al., 2010). Li et al. 
(2011) demonstrated that C. jejuni can stimulate the production of proinflammatory IL-8 and 
anti-inflammatory IL-10 in epithelial cells.  
1.7 Context of this study 
 
The perceived ability of mannan-containing feed additives to modulate the innate immune 
response of the host and to potentially reduce the colonisation levels of pathogenic agents such 
as C. jejuni, E. coli, Salmonella and Clostridium difficile warrants further investigation. This 
knowledge will be extremely beneficial in understanding the mechanism of action of yeast cell 
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wall derivatives and also possibly formulating additional alternatives to antibiotic-growth 
promoters. The data available for the effect of natural-feed additives is limited, and this 
research will help to fully elucidate the effect of dietary additives on a wide range of 
parameters, with the overall aim to find a better alternative to antibiotic-growth promoters. 
With respect to this, the objectives of this study were the following: 
- To determine if MRF supplementation could lead to alterations in intestinal 
enzyme capacity 
- To explore the role of MRF supplementation on intestinal tissue morphological 
features and integrity 
- To investigate if MRF incorporation leads to alterations in inflammatory cytokine 
expression 
- To fully delineate the effect of MRF supplementation on gut barrier function 
through analysis of cellular death levels
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Reagents        Supplier 
 
Acetic Acid glacial, ≥99.85% Sigma-Aldrich 
 
Acetic Acid Fisher-Scientific 
 



















DPX Mounting Medium Sigma-Aldrich 
 
DNA ladder & Loading dye 
 
Promega 




Glucose  Sigma-Aldrich 
 
































Periodic Acid Sigma-Aldrich 
 






Potassium Dichromate 99% 
 
Sigma-Aldrich 




























Tissue-Tek® Cryomold® Mold VWR 
 
Tissue-Tek® OCT Compound VWR 
 



















VectaMount Permanent Mounting Medium 
 
Vector Laboratories 
VECTASTAIN® ELITE® ABC HRP Kit (Peroxidase Rabbit IgG) Vector Laboratories 
 
 
Xylene, reagent grade 
 
Sigma-Aldrich 





10% Neutral Buffered Formalin Sigma-Aldrich 
 






Kit                Supplier 
 
In Situ Cell Death Detection Kit, Fluorescein Sigma-Aldrich 
 
Chicken IL-6 (Interleukin 6) ELISA Kit 96T 
 
Elabscience 
Chicken IL-10 (Interleukin 10) ELISA Kit 96T 
 
Elabscience 
Chicken IL-1β (Interleukin 1 Beta) ELISA Kit 96T 
 
Elabscience 
Chicken IL-18 (Interleukin 18) ELISA Kit 96T 
 
Abbexa 
Chicken IL-12 (Interleukin 12) ELISA Kit 96T 
 
Abbexa 
            
 






2.1.3.1 Antibodies for Immunoblotting 
 
Primary Antibody        Supplier             Dilution  Diluent 
 




Cell Signalling 1:1000 5% BSA TBST 
RIPK3 Biorbyt 1:150 
 
5% BSA TBST 
 
Secondary Antibody            Supplier     Dilution          Diluent 
Anti-mouse HRP Cell Signalling 
 
1:3000 5% Milk TBST 
Anti-rabbit HRP Cell Signalling 
 
1:3000 5% Milk TBST 
IRDye® 680RD Goat anti-Mouse  
 
Li-cor  1:5000  5% Milk TBST  
IRDye® 800CW Goat anti-Rabbit 
  
Li-cor  1:5000  5% Milk TBST  
 
2.1.3.2 Antibodies for Immunohistochemistry 
 
Antibody       Supplier      Dilution       Diluent 
Caspase-3 Abcam 1/75 PBST 
 













Buffer Name             Composition 
Block buffer (Immunoblotting) 
 
TBS, 0.1% (v/v) Tween-20 with 5% (w/v) 
non-fat dry milk 
 
Maleate Buffer 50mM Maleic Acid, 1M NaOH, pH 6, 




0.5M Trizma base, HCl, pH 7. 
Detergent 1part Triton X-100 with 4 parts 95% 
Ethanol 
 
Laemmli sample buffer 
 
62.5 mM Tris-HCl, pH 6.8, 10% (w/v) 
glycerol, 2% (w/v) SDS, 0.7 M β-
mercaptoethanol and 0.001% (w/v) 
bromophenol blue 
 
0.1% Peroxidase Solution 10mg 0.1% Peroxidase Solution to 
deionised water 
 
o-dianisidine dihydrochloride  50mg to 5mL deionised water 
 
Tris Glucose Oxidase (TGO) Solution 
(100mL) 
Tris-HCl, 1 % Detergent, 0.1% Peroxidase 
Solution, o-Dianisidine Dihydrochloride, 
0.1g Glucose Oxidase from Aspergillus 
Niger 
 
0.5% Periodic Acid Solution 0.5% Periodic Acid, Distilled Water 
 
1% Acid Alcohol 
 
2-Propanol (Isopropanol), dH2O, HCl 
Eosin Y 1g Eosin, 1.6g Potassium Dichromate, dH2O 
 
Permeabilisation Solution (TUNEL) 0.1% Triton X-100, 0.1% Sodium Citrate, 
dH2O 
 
Fixation Solution (TUNEL) 4% Paraformaldehyde, PBS, pH 7.4 
 
TUNEL Positive Control Solution 50mM Tris-HCl, 30U/mL DNase I 
Recombinant, BSA, pH 7.5 
 
Phosphate Buffered Saline (PBS) 2.7mM KCl, 1.5mM KH2PO4, 137mM 
NaCl, 8mM NaHPO4, pH 7.4 
 




Phosphate Buffered Saline Tween 20 
(PBST) 
2.7mM KCl, 1.5mM KH2PO4, 137mM 





0.1% (w/v) Ponceau S in 5% (v/v) acetic 
acid 
SDS running buffer 
 
25 mM Tris, 192 mM glycine, 0.1% SDS 
Tris buffered saline (TBS) 25 mM Tris, pH7.4, containing 0.14M NaCl 
 
0.3% H2O2 (Endogenous peroxidase 
activity) 





2.2.1 Trial Outline 
 
A 35-day trial involving 492 male broiler chickens was carried out to determine the possible 
effect, compared to a control (birds fed a normal corn and soybean diet), of three naturally-
derived dietary supplements on broiler intestinal health and immunity. The boiler chickens 
were housed on-site at Agri-Food Biosciences Institute (AFBI, Belfast, UK). The experiment 
was set up in a randomised complete block design with each bird allocated at random to each 
of 12 pens at day of hatch. Three pens were allocated for each treatment (41,41 and 43 birds 
respectively). The supplements were mannan-rich fractions (MRF) extracted from the cell wall 
of Saccharomyces cerevisiae. Basal diets consisted primarily of a standard wheat/soybean diet 
which met full dietary nutritional requirements. Feed and water were provided ad libitum. 
Broiler diets consisted of three distinct phases: starter (day 0 - day 10), grower (day 11 – day 
25) and finisher (day 26 – day 35). Broiler dietary supplements were tailored at each stage with 
supplements included at the manufacturer’s recommended inclusion levels. MRF-1 was 
incorporated at 1.3 kg/T, 1 kg/T and 0.6 kg/T in starter, grower and finisher feed, respectively. 
MRF-2 was supplemented into broiler diets at 1 kg/T for each stage. MRF-3 was incorporated 
into broiler diets at 1 kg/T for each phase. At day 0, 7, 21 and 35, all birds were weighed and 




the resulting values averaged per pen. In order to assess possible differences in weight gain and 
feed-conversion ratios, all feed intake was carefully monitored. All procedures were subject to 
the approval of the local Animal Welfare Ethics Review Board and subsequent approval by a 
Home Office Inspector. All procedures were carried out under the strict guidelines of the 
Animal (Scientific Procedures) Act 1986. 
2.2.2 Sample Collection and Preparation 
 
2.2.2.1 Sample Collection and Preparation 
 
Birds were sacrificed at day 35 by cervical dislocation followed by exsanguination. Biological 
tissue samples were retrieved from four intestinal sections per bird: the duodenum, jejunum, 
ileum and the caecum. At day 35, serum samples were also collected. Histological tissue 
samples were suspended in 1x phosphate buffered saline (PBS) and stored at 4°C overnight. 
The samples were then immersed in OCT compound, and placed in a cryomold and stored at -
80°C until further processing. Tissue samples for digestive enzyme analyses were flash frozen, 
kept on dry ice and finally stored at -80°C. 
2.2.2.2 Sample preparation- Digestive Enzyme Assays  
 
All steps were carried out on ice unless otherwise stated, and all equipment and labware were 
pre-chilled in advance of sample preparation. Tissue samples were removed from -80°C 
storage and kept on ice prior to homogenisation to prevent possible enzyme degradation. 
Segments weighing 10mg were removed from each intestinal tissue sample using a scalpel. 
Tissue segments were placed, using forceps, into a flat-bottomed plastic cylindrical tube 
containing 500µL of distilled water. Homogenisation was carried out using an T10 basic 
ULTRA-TURRAX® homogenizer at medium speed. Samples were homogenised for a total of 




2 minutes. Homogenised samples were aliquoted into 100µL Eppendorf tubes, briefly 
centrifuged and the supernatant stored at -20°C for further analyses. 
2.2.2.3 Sample Preparation- Histological Analyses 
 
Tissue samples embedded in OCT compound were removed from -80°C storage. Tissue 
sections were prepared using a Thermo Shandon Cryotome™ M165. The temperature of the 
chamber was set at -18°C. Tissue blocks were removed from Cryomold® mold and fitted inside 
the pre-chilled cryotome chamber and allowed to equilibrate to chamber temperature. Tissue 
sections were trimmed at 15µm until the full intestinal tissue was exposed. 10µm sections were 
then cut in continuous fashion and transferred onto VWR® microscopic slides. Three sections 
were placed on each slide. Slides were labelled and stored at -80°C prior to staining. Unused 
tissue blocks were re-embedded in OCT compound and returned to -80°C storage. 
2.2.3 Bradford Assay 
 
Total protein content of homogenised tissue was quantified using the Bradford method 
(Bradford, 1976). The Bradford assay was carried out using the microplate method. Pre-
determined concentrations of BSA standards and samples were diluted in 18µL of distilled 
water and mixed with 180µL of Bradford assay reagent. Protein concentration was determined 
by the resulting formation of colourimetric product. The OD value of each well was recorded 
at 595nm using a TECAN Infinite® M200 PRO with TECAN i-control™ software. Protein 
concentrations of homogenised sample were extrapolated from a BSA standard curve of known 
concentrations ranging from 5mg/mL to 0mg/mL. Samples were analysed in triplicate and 
standard concentrations in duplicate. Data analysis was carried out using GraphPad® Prism 5 
software (GraphPad® Software). 
 




2.2.4 Maltase Enzyme Capacity Analysis 
 
Maltase enzyme capacity was assayed using a tris-glucose oxidase (TGO) reaction according 
to the method of Dahlqvist (1968), with slight modification. The assay was carried out in two 
steps: first the intestinal homogenate was incubated in the presence of maltose substrate 
solution and then glucose product was recorded using a spectrophotometer after addition of 
TGO solution. Sample dilutions were carried out using ice-cold deionised water. 10µL of 
appropriately diluted intestinal homogenate was added to each well in triplicate of a NUNC™ 
Maxisorb 96-well plate in the presence of 10µL of substrate solution (50mM maleate buffer, 
1M NaOH, pH 6, 0.056M maltose). The plate was covered to prevent evaporation and 
incubated at 37°C for 15 minutes. A glucose standard curve was constructed in order to 
accurately record the concentration of glucose emitted which is proportional to digestive 
enzyme capacity. Glucose standards were prepared ranging from 200µg/mL to 0µg/mL with 
distilled water. Following the first incubation, 20µL of each standard was added to the plate in 
duplicate. 200µL of TGO solution was added to each well on the microplate and incubated for 
an additional 15 minutes. The absorption of standards and samples were recorded at 420nm 
using a TECAN Infinite® M200 PRO with TECAN i-control™ software. The concentration 
of glucose released from intestinal homogenate was determined by interpolating the sample 
absorbance from the known concentrations of the glucose standard curve. Sample 
concentrations were converted to µmol of glucose released per minute and results expressed as 
µmol glucose released per minute per µg protein content. Data analysis was carried out using 









2.2.5 Sucrase Enzyme Capacity Analysis 
 
Sucrase enzyme capacity was assayed using a TGO reaction according to the method of 
Dahlqvist (1968), with slight modification. The assay was carried out in two steps: first the 
intestinal homogenate was incubated in the presence of sucrose substrate solution and then 
glucose product was recorded using a spectrophotometer after addition of TGO solution. 
Sample dilutions were carried out using ice-cold deionised water. 10µL of appropriately diluted 
intestinal homogenate was added to each well in triplicate of a NUNC™ Maxisorb 96-well 
plate in the presence of 10µL of substrate solution (50mM maleate buffer, 1M NaOH, pH 6, 
0.056M sucrose). The plate was covered to prevent evaporation and incubated at 37°C for 15 
minutes. A glucose standard curve was constructed in order to accurately record the 
concentration of glucose emitted which is proportional to digestive enzyme capacity. Glucose 
standards were prepared ranging from 200µg/mL to 0µg/mL with distilled water. Following 
the first incubation, 20µL of each standard was added to the plate in duplicate. 200µL of TGO 
solution was added to each well on the microplate and incubated for an additional 15 minutes. 
The absorption of standards and samples were recorded at 420nm using a TECAN Infinite® 
M200 PRO with TECAN i-control™ software. The concentration of glucose released from 
intestinal homogenate was determined by interpolating the sample absorbance from the known 
concentrations of the glucose standard curve. Sample concentrations were converted to µmol 
of glucose released per minute and results expressed as µmol glucose released per minute per 
µg protein content.  Data analysis was carried out using GraphPad Prism 5 software 
(GraphPad® Software).  
 
 





2.2.6 Alkaline Phosphatase Enzyme Capacity Analysis 
 
Tissue homogenate was prepared and stored at -20°C prior to analysis. The procedure was 
carried out as per manufacturer’s instructions (Abcam). For the preparation of 5mM p-
nitrophenol phosphate (pNPP) solution, 2 pNPP tablets (sufficient for 100 assays) were re-
constituted in 5.4mL Assay Buffer. Concentrated ALP enzyme was diluted with 1mL Assay 
Buffer and kept on ice during the assay. Working solution of ALP enzyme was aliquoted and 
unused solution stored at 4°C. A pNPP standard curve was prepared ranging from 
20nmole/well to 0nmol/well. Optimal sample dilutions were calculated prior to analysis to 
ensure results fell within range of standard curve. Sample dilutions were carried out using 
Assay Buffer. Appropriately diluted sample was added to each well in triplicate and volume 
topped up to 80µL using Assay Buffer. 120µL of each standard was added to the plate in 
duplicate. Distilled water was used as a negative control. 20µL Stop Solution was immediately 
added to control well. 50µL of 5mM pNPP Solution was added to each sample and control 
well. 10µL of ALP enzyme solution was added to each pNPP standard well. The plate was 
covered and then incubated for 60 minutes at 25°C. The enzyme will convert pNPP substrate 
to an equal amount of coloured p-Nitrophenol (pNP). 20µL of Stop Solution was then added 
to each sample and standard well. The plate was placed on an ELISA shaker for 30 seconds 
and absorbance read at 405nm using a TECAN Infinite® M200 PRO with TECAN i-control™ 
software. pNP activity was determined by interpolating the sample absorbance from the known 
concentrations of the pNPP standard curve. Sample concentrations were converted to µmol of 
pNP released per minute and results expressed as µmol pNP released per minute per µg protein 
content. Data analysis was carried out using GraphPad Prism 5 software (GraphPad® 
Software). 
 




2.2.7 Histological Staining  
 
2.2.7.1 Haematoxylin & Eosin Y Staining (H&E Staining) 
 
Sections were fixed onto glass slides using 10% neutral buffered formalin (NBF) for 30 
minutes. The slides were then washed in 1x PBS for 2 minutes, twice. Sections were placed in 
xylene for 20 minutes. Samples were then dehydrated in 100% EtOH for 10 minutes. The 
sections were incubated in 95% EtOH and 80% EtOH for 2 minutes and rinsed in dH2O for 2 
minutes. The slides were then incubated in haematoxylin for 3 minutes and rinsed in running 
tap water until the excess haematoxylin was removed. The samples were decolourised in 1% 
acid alcohol for 20 seconds and rinsed in running tap water for 5 minutes. The sections were 
then immersed in eosin Y for 3 minutes and rinsed in running tap water for 5 minutes. The 
slides were then dehydrated in 80% EtOH for 5 minutes. This was followed by incubation in 
95% EtOH and 100% EtOH for 5 minutes each time. DPX mounting gel was added to each 
slide and a coverslip carefully lowered to avoid any air bubbles. Nail varnish was blotted onto 
the coverslip edge to anchor the coverslip. Slides were left to dry overnight. 
 
2.2.7.2 Periodic Acid-Schiff Staining 
 
 
Sections were fixed onto glass slides using 10% NBF for 30 minutes. The slides were then 
washed in 1x PBS for 2 minutes, twice. Sections were placed in xylene for 20 minutes. Samples 
were then rehydrated in 100% EtOH for 10 minutes. The sections were then incubated in 95% 
EtOH and 80% EtOH for 2 minutes and rinsed in dH2O for 2 minutes. The slides were oxidised 
in 0.5% periodic acid solution for 5 minutes and then rinsed in distilled water. Sections were 
placed in Schiff reagent for 15 minutes to allow tissue samples to develop a light pink colour. 




The slides were washed in lukewarm tap water for 5 minutes to allow sections to develop a 
dark pink colour. The tissue samples were counterstained in Mayer’s haematoxylin for 1 
minute and washed in tap water for 5 minutes. The slides were then dehydrated in 80% EtOH 
for 5 minutes. This was followed by incubation in 95% EtOH and 100% EtOH for 5 minutes. 
DPX mounting gel was added to each slide and a coverslip carefully lowered to avoid any air 
bubbles. Nail varnish was blotted onto the coverslip edge to anchor the coverslip. Slides were 
left to dry overnight. 
 
2.2.8 TUNEL Staining 
 
 
TUNEL staining was carried out using the in situ Cell Death Detection Kit, Fluorescein 
(Roche), according to manufacturer’s instructions, with slight modifications. Intestinal tissue 
sections were fixed with 4% paraformaldehyde in PBS, pH 7.4 for 20 minutes at room 
temperature (RT). Slides were then washed in PBS for 30 minutes. Sections were incubated in 
permeabilisation solution for 2 minutes at 4°C. TUNEL reaction mixture was prepared by 
adding 50µL enzyme solution to 450µL label solution. 50µL of TUNEL positive control 
solution was added to the positive control slide and incubated at RT for 10 minutes. Slides were 
rinsed twice in PBS and the area around the samples dried. 50µL of the TUNEL reaction 
mixture was added to each slide and 50µL of label solution added to the negative control slide. 
All samples were incubated in a humidified chamber for 1 hour at 37°C in the dark. Tissue 
samples were rinsed 3 times with PBS for 3 minutes and two separate drops of Gel Mount-
DAPI was added to each slide. A coverslip was carefully lowered onto sample to avoid any air 
bubbles. Tissue intestinal samples were analysed using fluorescence microscopy (Olympus 
IX81) and images were obtained using 20x magnification. The apoptotic index (AI) was used 




as a quantitative measure of apoptosis in tissue samples. This index is defined as the percentage 
of apoptotic cells per total number of analysed cells. The apoptotic index can be described by 
the following formula: 
Apoptotic Index (AI) =   
Number of TUNEL positive cells∗100
Total number of nuclei analysed
    
    
2.2.9 Histological Analyses 
 
2.2.9.1 Villus Height, Villus Surface Area and Crypt Depth   
 
Villus height (VH), villus surface area (VSA) and crypt depth (CD) were analysed using H&E 
staining. Morphometric investigations for VH was calculated as the average of 15 vertically-
orientated villi from a total of 9 birds. Data was expressed in µm. VSA was calculated as the 
average of 15 vertically-orientated villi per bird from a total of 9 birds using the following 
equation as adapted from Iji et al. (2001): 
𝑉𝑆𝐴 =  ((𝑉𝑖𝑙𝑙𝑢𝑠 ℎ𝑒𝑖𝑔ℎ𝑡 𝑎𝑡
1
3
ℎ𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑣𝑖𝑙𝑙𝑢𝑠 + 𝑣𝑖𝑙𝑙𝑢𝑠 ℎ𝑒𝑖𝑔ℎ𝑡 𝑎𝑡 
2
3
 ℎ𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑣𝑖𝑙𝑙𝑢𝑠) ∗ 2−1 ∗ 𝑣𝑖𝑙𝑙𝑢𝑠 ℎ𝑒𝑖𝑔ℎ𝑡) 
Crypt depth was calculated as the average of 20 well-defined crypts from a total of 9 birds. 
Data was expressed in µm. Two sections of each tissue were analysed per bird for each 
morphological measurement.   
2.2.9.2 Muscularis Mucosae Thickness, Mucus Layer Thickness and Goblet Cell 
Density 
 
Muscularis mucosae layer thickness was examined using Periodic Acid Schiff (PAS) staining 
and expressed in µm. Five points along the muscularis layer from each bird was measured for 
an average value from a total of 9 birds. Goblet cell density was calculated by counting the 
number of goblet cells present on the midpoint of the villus (165µm) on a total of 5 vertically-




orientated villi per bird to find an average value from a total number of 9 birds. Mucus layer 
thickness was expressed using the PAS stain and counterstaining with haematoxylin. Data was 
expressed from an average of 5 measurements per bird from a total of 9 birds. Two sections 
were analysed per bird for each morphological measurement. 
2.2.10 Enzyme-Linked Immunosorbent Assay (ELISA) 
 
2.2.10.1 IL-6, IL-10 and IL-1β ELISA 
 
Samples (intestinal tissue homogenate (see section 2.2.2.2) and serum) were collected and 
stored at -20°C prior to ELISA analysis which was carried out using the chicken IL-6, IL-10 
and IL-1β ELISA kits from Elabscience. Micro ELISA plate strips were pre-coated with 
antibody against IL-6, IL-10 and IL-1β. 100µL of standards ranging from 15pg/mL to 
1000pg/mL for IL-6 and IL-10 and concentrations ranging from 6.25pg/mL to 400pg/mL for 
IL-1β were added to pre-determined wells. Standard dilutions were carried out using reagent 
diluent. 100µL of reagent diluent was added to designated wells to act as a blank (0pg/mL). 
100µL of serum or appropriately diluted intestinal tissue homogenate sample was added to 
each sample well and gently mixed. Intestinal tissue homogenate samples were diluted in 
reagent diluent. Plates were sealed with an adhesive film to prevent possible evaporation and 
incubated in a humidified chamber at 37°C for 90 minutes. After incubation, the contents of 
the plates were decanted and 100µL of biotinylated detection antibody was added to each well. 
The adhesive film was re-applied to the plates and gently tapped to ensure thorough mixing 
and incubated at 37°C for 1 hour. Plates were then washed three times with wash buffer 
(320µL) provided and dried against thick clean absorbent paper to ensure complete removal of 
residual wash buffer. The plates were placed on an orbital shaker during wash steps. 100µL of 
horseradish peroxidase (HRP) conjugate was then added to each well and plates were sealed 
with new adhesive film and incubated for 30 minutes at 37°C. After incubation, plates were 




again washed five times using wash buffer provided and 90µL of Substrate Solution was added 
to each well. The micro ELISA plates were then incubated at 37°C in the dark for 15 minutes. 
The reaction was stopped by the addition of 50µL of stop solution. The optical density (OD) 
was determined for each well at 450nm and 590nm using a ELx800TM microplate reader with 
Gen5 Data Analysis software (Biotek™). The concentrations of IL-6, IL-10 and IL-1β in each 
experimental sample were extrapolated from a standard curve of known concentrations. 
Standard samples were added in duplicate to ensure accurate readings. Data analysis was 
carried out using GraphPad Prism 5 software (GraphPad® Software).  
2.2.10.2 IL-12 and IL-18 ELISA 
 
Samples (intestinal tissue homogenate and serum) were collected and stored at -20°C prior to 
ELISA analysis which was carried out using the chicken IL-12 and IL-18 ELISA kit from 
Abbexa. Micro ELISA plate strips were pre-coated with antibody against IL-12 and IL-18. 
100µL of standards ranging from 31pg/mL to 2000pg/mL for (IL-12) and ranging from 7pg/mL 
to 500pg/mL (for IL-18) were added to designated wells. Standard dilutions were carried out 
using sample diluent. 100µL of sample diluent was added to designated wells to act as a blank 
(0pg/mL). 100µL of serum or appropriately diluted intestinal tissue homogenate sample was 
added to each sample well and gently mixed. Intestinal tissue homogenate samples were diluted 
in sample diluent. Plates were sealed with an adhesive film to prevent possible evaporation and 
incubated in a humidified chamber at 37°C for 2 hours. After incubation, the contents of the 
plates were decanted and 100µL of detection reagent A was added to each well. The adhesive 
film was re-applied to the plates and gently tapped to ensure thorough mixing and incubated at 
37°C for 1 hour. Plates were then washed three times with wash buffer (320µL) provided and 
dried against thick clean absorbent paper to ensure complete removal of residual wash buffer. 
The plates were placed on an orbital shaker during wash steps. 100µL of detection reagent B 




was then added to each well and plates were sealed with new adhesive film and incubated for 
1 hour at 37°C. After incubation, plates were washed five times using wash buffer provided 
and 90µL of TMB Substrate Solution was added to each well. The micro ELISA plates were 
then incubated at 37°C in the dark for 25 minutes. The reaction was stopped by the addition of 
50µL of stop solution. The optical density (OD) was determined for each well at 450nm and 
590nm using a ELx800TM microplate reader with Gen5 Data Analysis software (Biotek™). 
The concentrations of IL-12 and IL-18 in each experimental sample were extrapolated from a 
standard curve of known concentrations. Standard samples were added in duplicate to ensure 
accurate readings. Data analysis was carried out using GraphPad Prism 5 software (GraphPad® 
Software).  
2.2.11 Immunohistochemical Analyses 
 
2.2.11.1 Caspase-3 and receptor-interacting protein kinase 3 (RIPK3) 
 
Tissue sections were stored at -80°C prior to immunohistochemical analyses. Slides were 
removed from cold storage and allowed to come to room temperature prior to fixation. Slides 
were fixed using 4% paraformaldehyde (v/v) for 25 minutes in fumehood. Samples were then 
rinsed 2x times in 300mL of 10mM PBS, pH 7.4 for 5 minutes. Endogenous peroxidase activity 
was blocked using 0.3% (v/v) H2O2 in water for 30 minutes. Sections were washed 2x in PBS-
Tween®-20 (PBST) for 5 minutes. Tissue sections were then incubated for 1 hour with 2.5% 
normal goat serum blocking solution (Vector Labs). After incubation, excess serum was blotted 
from sections and slides were washed in PBS. Sections were then incubated with primary 
antibody overnight diluted in PBST at 4°C as per dilutions outlined in Section 2.1.3.1. 
Following primary antibody incubation, slides were washed 2x with PBST for 5 minutes. 
Tissue samples were then incubated for 45 minutes with VECTASTAIN ® Elite ® goat anti-
rabbit biotinylated secondary antibody (Vector Labs). VECTASTAIN ® ABC reagent was 




prepared 30 minutes after biotinylated secondary antibody incubation. Following secondary 
antibody incubation, slides were washed 3x times in PBST, for 5 minutes. Sections were then 
incubated in VECTASTAIN ® ABC reagent mixture for 40 minutes. Samples were washed 3x 
times in PBST. Tissue sections were incubated in DAB peroxidase (HRP) substrate kit until 
the desired stain intensity developed and then rinsed with tap water. Following DAB substrate 
incubation, sections were rinsed in distilled water for 1 minute. The slides were then incubated 
in haematoxylin for 20 seconds and rinsed several times with water. The samples were 
dehydrated in 85% EtOH for 5 minutes. This was followed by incubation in 95% EtOH and 
100% EtOH for 5 minutes. DPX mounting gel was added to each slide and a coverslip carefully 
lowered to avoid any air bubbles. Nail varnish was blotted onto the coverslip edge to anchor 
the coverslip. Tissue intestinal samples were analysed using light microscopy (Nikon® Eclipse 
E600) and images were obtained using 40x magnification. 
 
2.2.12 Protein Immunoblotting 
 
2.2.12.1 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
SDS-PAGE was conducted according to the method of Laemmli (Laemmli, 1970) as modified 
by Studier (Studier, 1973). Samples were prepared by performing protein equalisation and 
denaturing in SDS-PAGE by boiling for 5 minutes at 95˚C. Sample and pre-stained protein 
markers (Promega, 10-250kDa) were loaded into separate wells. Electrophoresis was 
performed initially at 70V through a 5% SDS polyacrylamide stacking gel and then through an 
8-15% polyacrylamide resolving gel at 100V for 1.5-2 hours. The percentage gel chosen was 
dependant on the predicted size of the protein of interest with lower percentage gels prepared 
for the identification of higher molecular weight proteins.  






Following the separation of proteins by electrophoresis, the protein gel was transferred 
electrophoretically to nitrocellulose membranes in a Hoefer TE 70 Semiphor semi-dry transfer 
unit at 200mA for 120 minutes. Pre-cut Whatmann filter paper and nitrocellulose were 
equilibrated with cold 1X Transfer buffer (25mM Tris Base, 0.2M glycine and 20% (v/v) 
methanol) 5 minutes prior to addition to transfer unit. Three layers of Whatmann paper were 
placed on the bottom surface on the transfer unit followed by one layer of nitrocellulose. The 
resolving gel was removed from the electrophorator, washed briefly in transfer buffer and then 
placed on the nitrocellulose. Finally, three more layers of Whatmann filter paper were added 
to the sandwich and the unit was closed. Following the transfer, the membrane was stained 
with Ponceau S to ensure correct transfer of proteins and rinsed in TBST. The membrane was 
then blocked with TBST containing 5% (w/v) skimmed milk powder on an orbital shaker for 
15 minutes at room temperature to prevent non-specific antibody binding to membrane. The 
membranes were incubated in the presence of primary antibody diluted in either TBST 
containing 5% (w/v) skimmed milk powder or TBST containing 5% (w/v) BSA overnight at 
4°C as per dilutions outlined in Section 2.1.3.1. Following incubations, the membranes were 
washed in TBST 3x times for 5 minutes on the shaker. Membranes were then incubated in a 
secondary antibody specific to the primary antibody diluted in TBST containing 5% (w/v) 
skimmed milk powder (anti-rabbit, anti-mouse or anti-goat) at RT for 1 hour. The nitrocellulose 
membranes were then washed 3x times in TBST under constant agitation. The immunoreactive 
bands were then visualised using the Odyssey infrared imaging system from Licor Biosciences 
or using enhanced chemiluminescence development (ECL) for sensitive proteins.  
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The innate immune system represents the initial line of defence from invading microorganisms 
(Netea et al., 2016). This system is characterised by the presence of immune cells such as 
macrophages, natural killer cells, neutrophils and dendritic cells in addition of the action of 
PRRs upon recognition of their respective stimuli (Thaiss et al., 2016). The activation of PRRs 
such as TLRs in response to their antigenic stimuli results in the upregulation of several 
inflammatory signalling components such as NF-κB and MAPK and the onset of adaptive 
immunity, a more specific response to the threat posed by antimicrobial peptides. (Thaiss et 
al., 2016).  
The intestinal tract is exposed to a diverse range of foreign particles and microbial species. The 
epithelial layer of the intestinal tract acts as a selective barrier, obstructing the passage of these 
potentially pathogenic organisms into systemic circulation and possibly initiating an 
inflammatory response (Snoeck et al., 2005). The mucus layer is composed of mucin 
glycoproteins which provide an extremely efficient system for preventing the adherence of 
bacteria to the epithelial layer (Cornick et al., 2015). Breakdowns in the function and integrity 
of this mucosal barrier can lead to alterations in intestinal homeostasis, and the onset of various 
inflammatory disorders, such as necrotic enteritis and ulcerative colitis (Cornick et al., 2015; 
O'Reilly et al., 2017). 
It has been suggested the MRF dietary inclusion into animal diets can lead to an increased bird 
weight gain and an enhanced immune response (Corrigan et al., 2017; Wang et al., 2017). The 
enhanced immune defence (as a result of increased mucin production or improved integrity of 
the gastrointestinal barrier) in broilers may result in lower incidences of disease occurrence 
through a reduction in pathogen colonisation levels, thereby enhancing the partitioning of 
available nutrients towards productive processes such as bird weight gain and feed conversion 




ratios. The capacity of digestive enzymes to break down and absorb available nutrients plays 
an essential role in enhanced broiler weight gain. Despite the research into the role naturally-
derived dietary supplements can play on bird weight gain and performance, the impact of 
dietary supplements on the expression of pro- and anti-inflammatory cytokines remains to be 
fully delineated. The effect of dietary supplements on intestinal tissue morphology and the 
expression of markers of cellular death remains a significant topic in research, as they can be 
informative towards the overall health of the host. Efficient and regulated levels of cell death 
are essential for the maintenance of optimal gut barrier function (Delgado et al., 2016). 
Apoptosis is generally considered an anti-inflammatory process, due to the diminished activity 
of DAMPs (Szondy, Sarang, Kiss, Garabuczi, & Köröskényi, 2017). Necrotic cell death, 
conversely, has been shown to convey pro-inflammatory properties, potentially resulting in 
excessive inflammation and epithelial barrier dysfunction (Davidovich et al., 2014).  
The work presented in this thesis aims to investigate the effect of natural-derived dietary 
supplements on the levels of digestive enzymes maltase, sucrase and alkaline phosphatase. The 
potential effect of MRF incorporation on intestinal tissue histological parameters will also be 
examined to determine if MRF supplementation can improve tissue morphology. Analyses of 
the effect of MRF inclusion on inflammatory cytokine expression levels in serum and gut 
homogenate will also be carried out in addition to examinations of cellular death levels as a 
measure of gastrointestinal barrier integrity and function, with overall implications for broiler 












3.2.1 Mannan-rich fraction supplementation results in alterations to gut tissue 
morphology 
 
Table 3.1 Effect of mannan-rich fraction supplementation on intestinal mucosal 
morphometry of broiler chickens at day 35. 
Statistical significance between control and each treatment was determined using two-tailed 
Student’s t-test (*P<0.05; **P<0.01; ***P<0.001). 
1




Control           MRF-1                   MRF-2            MRF-3 
 
 
  Villus Height (µm) 
 
    
 Duodenum 1157.71±41.82 1623.83 ±56.33*** 1256.01±59.58 1506.29±51.61*** 
 
 Jejunum   
 
901.49 ±20.75 1187.70 ±47.47*** 1132.53±50.28*** 1156.68±63.57** 
 
 Ileum    
 
529.73 ±18.83 731.97 ±22.47*** 736.14±29.29*** 676.21±38.48** 
 
Caecum   
 
231.39 ±9.66 315.70 ±5.26*** 327.30±9.52*** 317.28±17.96** 
 
    Villus Surface Area (VSA) (mm2)  
 
   
 Duodenum 0.16±0.02 0.24±0.01*** 0.20 ±0.01        0.21 ±0.01* 
 
 Jejunum   
 
0.10 ±0.01 0.15±0.01*** 0.13 ±0.01** 0.12 ±0.01* 
 
 Ileum    
 
0.05±0.01 0.09 ±0.01*** 0.09±0.01** 0.07±0.01* 
 
Caecum   
 
0.01±0.001 0.02±0.001*** 0.02±0.001*** 0.02±0.001** 
 
   Crypt Depth (µm) 
 
    
 Duodenum 160.63±13.74 235.47±6.94*** 254.77±20.36** 209.63±7.80** 
 
 Jejunum   
 
120.88±6.29 172.09±8.10*** 228.37±11.90*** 143.20±6.15* 
 
 Ileum    
 
82.61±3.43 139.39±4.70*** 178.29±7.13*** 111.64±2.66*** 
 
Caecum   
 
111.71±5.38 104.00±2.88 121.82±8.45 144.03±8.16** 
 
   Muscularis Mucosae Thickness (µm)  
 
  
 Duodenum 41.33±1.84 29.62±1.65*** 28.07±0.58*** 29.13±1.25*** 
 
 Jejunum   
 
47.96±1.14 37.11±1.41*** 37.47±1.61*** 31.91±2.31*** 
 
 Ileum    
 
51.16±2.04 45.76±1.40* 41.62±1.45** 43.44±1.77* 
 
Caecum   
 
32.91±1.88 26.07±1.10** 26.51±1.56* 26.76±0.70** 
 





  Control     MRF-1     MRF-2       MRF-3            
 
   Mucus Layer Thickness (µm)  
 
    












18.13±0.50 22.24±0.52*** 22.07±0.34*** 20.78±0.84* 
  
 




     












9.00±0.22   9.83±0.33    10.34±0.26** 10.43±0.21*** 
  
 
Table 3.2 Effect of mannan-rich fraction supplementation on intestinal mucosal 
morphometry of broiler chickens at day 35. 
Statistical significance between control and each treatment was determined using two-tailed 
Student’s t-test (*P<0.05; **P<0.01; ***P<0.001). 
1












       
 




Figures 3.1 Representative samples demonstrating the effect of mannan-rich fraction 
supplementation on in situ villus height in broiler chickens at day 35. 
Representative samples of effect of (A) control diet, (B) MRF-1 supplementation, (C) MRF-2 
supplementation and (D) MRF-3 supplementation on villus height in duodenum from chicken 
35 days after diet supplementation. Samples were stained with H&E. Morphometric 
investigations for VH was calculated as the average of 15 vertically-orientated villi from a total 
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Figures 3.2 Representative samples demonstrating the effect of mannan-rich fraction 
supplementation on in situ crypt depth in broiler chickens at day 35. 
Representative samples of effect of (A) control diet, (B) MRF-1 supplementation, (C) MRF-2 
supplementation and (D) MRF-3 supplementation on crypt depth in jejunum from chicken 35 
days after diet supplementation. Samples were stained with H&E. Morphometric investigations 
for crypt depth was calculated as the average of 20 well-defined crypts from a total of 9 birds 













           
 
                    
            
 
Figures 3.3 Representative samples demonstrating the effect of mannan-rich fraction 
supplementation on in situ goblet cell density in broiler chickens at day 35. 
Representative samples of effect of (A) control diet, (B) MRF-1 supplementation, (C) MRF-2 
supplementation and (D) MRF-3 supplementation on goblet cell density in ileum from chicken 
35 days after diet supplementation. Samples were stained with Periodic Acid Schiff (PAS) 
staining. Data was expressed from an average of 5 measurements per bird from a total of 9 
birds under 40x magnification. Two sections were analysed per bird for each morphological 
measurement 
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Given that mannan-rich fractions (MRF) have been hypothesised to potentially alter tissue 
integrity in the intestine, it was important to identify if MRF supplementation could result in 
improvements in intestinal tissue morphology. To this end, intestinal tissue sections were 
prepared and stained using H&E staining. The villus height (VH), villus surface area (VSA) 
and crypt depth (CD) from a total of 9 birds per treatment was measured using light microscopy 
and ImageJ software. Incorporation of MRF-1 (Figure 3.1B), MRF-2 (Figure 3.1C) and MRF-
3 (Figure 3.1D) into broiler diet resulted in a significant increase in VH in each intestinal 
section with the exception of MRF-2 incorporation in the duodenum (Table 3.1 & Figure 3.1 
A-D). The effect of MRF supplementation on VSA was similar to the results observed for VH 
(Table 3.1). Incorporation of MRF-1, MRF-2 and MRF-3 into broiler diet resulted in a 
significant increase in VSA in each intestinal section. The increase in VH and VSA upon 
mannan-rich fraction dietary supplementation compared to the control may increase the surface 
area available for nutrient absorption (Baurhoo et al., 2007). Mannan-rich fraction dietary 
inclusion also resulted in a significant increase in crypt depth in small intestinal tissue for each 
treatment (Table 3.1 & Figure 3.2 A-D). MRF-1 (Figure 3.2B) dietary inclusion into broiler 
diet resulted in a slight decrease in crypt depth in caecal tissue compared to the control (Figure 
3.2A), whereas MRF-3 (Figure 3.2D) supplementation led to a significant increase in crypt 
depth in the caecum. The incorporation of MRF-2 (Figure 3.2C) into broiler diet resulted in a 
slight increase in crypt depth, suggesting an overall differing effect of MRF supplementation 
on small intestinal and caecal crypt depth. The crypt is involved in the formation of new 
intestinal cells (Benites et al., 2008). The base of these crypts house intestinal stem cells, which 
are involved in the formation of each epithelial cell type present in the crypt and the villi 
(Benites et al., 2008). The increase in crypt depth observed in small intestinal tissue (Table 3.1) 
as a result of mannan-rich fraction incorporation may potentially result in a more developed 
villus. 




Since it was demonstrated that MRF addition into broiler diet may result in alterations to 
intestinal tissue morphology that could potentially enhance nutrient absorption in broiler 
chickens, the next step involved examining if MRF incorporation could convey an increased 
protection from pathogenic invasion and adhesion, thereby permitting the greater volume of 
available nutrients to be utilised for enhancing bird performance and growth. To achieve this, 
intestinal tissue sections from each treatment were stained using PAS staining. Muscularis 
mucosae thickness, goblet cell density and mucus layer thickness were examined from a total 
of 9 birds per treatment. Dietary incorporation of each fraction led to a significant decrease in 
muscularis mucosae thickness in each intestinal section compared to the control (Table 3.1). 
Goblet cell density was significantly increased as a result of MRF-1 (Figure 3.3B) dietary 
inclusion in intestinal tissue while MRF-2 (Figure 3.3C) incorporation into broiler diet 
significantly enhanced goblet cell density in each intestinal tissue (Table 3.2 and Figure 3.3 A-
D). MRF-3 (Figure 3.3D) supplementation resulted in a significant increase in goblet cell 
density in the duodenum, jejunum, ileum and the caecum (Table 3.2). The thickness of the 
mucus layer was increased significantly in each intestinal tissue upon MRF dietary inclusion 
with the exception of MRF-3 in the ileum (Table 3.2). The muscularis mucosae acts as a 
boundary between the mucosal and submucosal layer of the GIT (Cheng et al., 2010). A 
decrease in the thickness of this layer may in theory assist in the translocation of nutrients into 
systemic circulation (Cheng et al., 2010). The increase in goblet cell density and corresponding 
increase in mucus layer thickness as a result of MRF supplementation suggest towards an 
increased protective effect compared to the control unsupplemented broiler chickens. Goblet 
cells secrete mucin glycoproteins which from a protective mucus layer that protects the 
intestinal epithelium from bacterial adhesion (Johansson et al., 2013).  
These results suggest that MRF incorporation into broiler diet can lead to an increase in surface 
area available for nutrient absorption and an enhanced protection from pathogenic invasion.  




3.2.2 MRF-1 and MRF-2 dietary supplementation leads to enhanced digestive 





Figure 3.4 Effect of mannan-rich fraction supplementation on maltase digestive enzyme 
capacity 
Digestive enzyme capacity analysis of maltase enzyme per µg of intestinal tissue lysate in 
duodenum, jejunum, ileum and caecum on day 35. The four bars represent, from left to right, 
control unsupplemented, MRF-1 supplement, MRF-2 supplement and MRF-3 supplement. 
Data are presented as the mean +/- SEM of maltase activity normalised per µg of homogenate 
proteins from 10 birds. Statistical significance between control and each treatment was 












Given that mannan-rich fractions have been hypothesised to potentially alter digestive enzyme 
capacity in the GIT, the initial analyses to assess the efficacy of mannan-rich dietary 
interventions focused on its potential to affect digestive enzyme maltase capacity. Intestinal 
tissue from broiler chickens (n=10) was homogenised and assayed for maltase enzyme capacity 
by means of maltose substrate solution and TGO solution. The digestive enzyme maltase was 
chosen for analysis as it plays an essential role in providing energy for maintenance and for 
growth (Horvatovic et al., 2015). Enzyme capacity was assessed through enzymatic assays. 
Incorporation of MRF-1 into broiler diet led to a significant increase in maltase enzyme 
capacity in the jejunum, ileum and caecum (Fig. 3.4). Supplementation of broiler diet with 
MRF-2 resulted in significantly enhanced enzyme capacity compared to the control in the 
duodenum, jejunum and caecum (Fig. 3.4) whereas dietary inclusion of MRF-3 led to a 
significant decrease in enzymatic capacity in the duodenum and a decrease (not reaching 
statistical significance) in maltase capacity in the jejunum, ileum and caecum (Fig. 3.4). These 
results indicate that MRF-1 and MRF-2 incorporation into broiler diet may result in enhanced 











3.2.3 MRF-1 and MRF-2 dietary supplementation leads to enhanced digestive 




Figure 3.5 Effect of mannan-rich fraction supplementation on sucrase digestive enzyme 
capacity 
Digestive enzyme capacity analysis of sucrase enzyme per µg of intestinal tissue lysate in 
duodenum, jejunum, ileum and caecum on day 35. The four bars represent, from left to right, 
control unsupplemented, MRF-1 supplement, MRF-2 supplement and MRF-3 supplement. 
Data are presented as the mean +/- SEM of sucrase activity normalised per µg of homogenate 
proteins from 10 birds. Statistical significance between control and each treatment was 













Since the data above suggests that MRF-1 and MRF-2 dietary inclusion can result in enhanced 
digestive enzyme maltase, it was important to ascertain whether MRF supplementation can 
alter the enzymatic capacity of the sucrose, an enzyme that catalyse hydrolysis of the 
disaccharide sucrose. To achieve this, tissue lysates from broiler chickens (n=10) were assayed 
for sucrase enzyme capacity in the presence of sucrose substrate solution and TGO solution. 
Digestive enzyme sucrase was chosen for analysis as it hydrolyses sucrose to fructose and 
glucose, playing a significant role in carbohydrate digestion (Horvatovic et al., 2015). Enzyme 
capacity was assessed through enzymatic assays. Supplementation of MRF-1 led to a 
significant increase in sucrase enzyme capacity in the jejunum and the caecum (Fig. 3.5). 
Incorporation of broiler diet with MRF-2 resulted in a significant increase in enzyme capacity 
in the duodenum, jejunum and caecum (Fig. 3.5) while integration of MRF-3 into broiler diet 
led to a significant decrease in the duodenum and a reduction (not reaching statistical 
significance) in sucrase enzyme capacity in the jejunum and the caecum, compared to the 
control (Fig. 3.5). These results indicate that MRF-1 and MRF-2 incorporation into broiler diet 
may result in enhanced digestive enzyme sucrase capacity, permitting the absorption of a 
greater volume of nutrients. This result was consistent with the findings that MRF-1 and MRF-










3.2.4 MRF-1 and MRF-2 dietary supplementation leads to enhanced alkaline 




Figure 3.6 Effect of mannan-rich fraction supplementation on alkaline phosphatase 
digestive enzyme capacity 
Digestive enzyme capacity analysis of alkaline phosphatase per µg of intestinal tissue lysate in 
duodenum, jejunum, ileum and caecum on day 35. The four bars represent, from left to right, 
control unsupplemented, MRF-1 supplement, MRF-2 supplement and MRF-3 supplement. 
Data are presented as the mean +/- SEM of alkaline phosphatase activity normalised per µg of 
homogenate proteins from 10 birds. Statistical significance between control and each treatment 













Given that MRF-1 and MRF-2 appear to enhance the enzymatic capacity of the disaccharides 
maltase and sucrase, potentially increasing the amount of carbohydrates available to the host, 
the role of MRF incorporation on alkaline phosphatase enzyme capacity was next elucidated. 
Tissue lysates from broiler chickens (n=10) were assayed for alkaline phosphatase using the 
ALP assay kit (colourimetric) from Abcam, as per the manufacturer’s instructions. Alkaline 
phosphatase was selected for analysis as it regulates the secretion of bicarbonate, which 
protects the cells lining the GIT from potential damage due to bacterial invasion (Bilski et al., 
2017). The enzymatic capacity of ALP was measured through a colourimetric reaction. 
Incorporation of MRF-1 led to a significant increase in maltase enzyme capacity in the jejunum, 
ileum and the caecum compared to the control (Fig. 3.6). Supplementation of broiler diet with 
MRF-2 resulted in significantly enhanced enzyme capacity in the jejunum and the ileum (Fig. 
3.6), whereas addition of MRF-3 led to a significant decrease in alkaline phosphatase enzyme 
capacity in the duodenum and jejunum with a slight increase in the caecum (Fig. 3.6). These 
results suggest that MRF-1 and MRF-2 integration into broiler diet results in enhanced alkaline 
phosphatase enzyme capacity, thereby potentially providing increased protection from 
pathogenic invasion and adhesion. 
The overall results from the digestive enzyme capacity analyses indicated that MRF-1 and 
MRF-2 incorporation into broiler diet resulted in enhanced digestive enzyme capacity, which 








3.2.5 Mannan-rich fraction dietary supplementation leads to alteration of in situ 
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Figure 3.7 Effect of mannan-rich fraction supplementation on intestinal apoptosis, as 
measured by TUNEL staining in broiler chickens at day 35 
Broiler chickens were supplemented with control chow diets or supplemented with MRF-1, 
MRF-2, MRF-3. (A) Intestinal tissue was processed for TUNEL staining with index of 
apoptosis calculated as % of cells that show positive TUNEL staining. Representative images 
of TUNEL staining of ileal intestinal tissue from chickens fed on (B) Control diet, (C) MRF-
1, (D) MRF-2 and (E) MRF-3 are also shown. Data are presented as the mean +/- SEM from 9 
birds for TUNEL staining with four sections analysed per bird under 20x magnification. 
Statistical significance between control and each treatment was determined using two-tailed 




























    
 
 
      
 
 
Figures 3.8 Effect of mannan-rich fraction supplementation on intestinal apoptosis, as 
measured by Caspase-3 immunostaining in broiler chickens at day 35 post 
supplementation 
Broiler chickens were supplemented with control chow diets or supplemented with MRF-1, 
MRF-2, MRF-3. (A) Intestinal tissue was processed for caspase-3 staining with caspase-3 
positive cells indicated as % of cells that show positive caspase-3 staining. Representative 
images of caspase-3 staining of duodenal intestinal tissue from chickens fed on (B) Control 
diet, (C) MRF-1, (D) MRF-2 and (E) MRF-3 are also shown. Data are presented as the mean 
+/- SEM from 5 birds for caspase staining with four sections analysed per bird under 40x 
magnification. Statistical significance between control and each treatment was determined 
















The above data (Section 3.2.2- 3.2.4) suggests that MRF supplementation into broiler chicken 
diet results in enhanced activity or levels of digestive enzymes that will feed carbohydrate 
metabolism whilst histological data suggest that supplementation can also change tissue 
architecture to a form that would suggest increased protective barrier against infection. Given 
such morphological and structural changes, studies were then conducted to assess if MRF 
supplementation could regulate cell death in intestinal tissue. Tissue samples were first 
examined for levels of apoptosis. Apoptosis is an immunologically silent form of cell death, 
essential for the maintenance of cellular homeostasis (Szondy et al., 2017). In order to assess 
the levels of apoptosis, TUNEL staining and caspase-3 immunohistochemical analysis was 
carried out on each intestinal segment. DNA fragmentation in intestinal tissue sections from 
broiler chickens was identified using the in situ cell death detection kit (fluorescein) from 
Roche, as per the manufacturer’s instructions. TUNEL-positive cells (cells undergoing 
extensive DNA damage as a consequence of the process of apoptosis) were quantified in each 
intestinal section from a total of 9 birds per treatment. Supplementation of MRF-1 (Fig. 3.7C) 
into broiler diet resulted in a significant decrease in TUNEL positive cells in the duodenum 
and jejunum (Fig. 3.7A). The incorporation of MRF-2 (Fig. 3.7D) and MRF-3 (Fig. 3.7E) to 
the diet had no statistically significant effects on the number of TUNEL positive cells (Fig. 
3.7A). The effect of MRF-1 (Fig. 3.7C) incorporation into broiler diet on cellular apoptosis 
seemed to be less pronounced towards the ileum and the caecum. Since TUNEL is a measure 
of DNA fragmentation, these data were also supported by analysis of processed levels of 
caspase-3, one of the executioner caspases in the apoptotic pathway. Immunohistochemical 
analysis of caspase-3 positive cells (Fig. 3.8A) revealed a similar trend to the results observed 
for TUNEL staining (Fig. 3.7A). Dietary inclusion of MRF-1 (Fig. 3.8C) resulted in no change 
in caspase-3 positive cells in the duodenum, jejunum and the caecum (Fig. 3.8A). Whilst 
integration of MRF-2 (Fig. 3.8D) into broiler diet led to a decrease in caspase-3 positive cells 




in the duodenum and caecum, this did not reach statistical significance (Fig. 3.8A). 
Supplementation of MRF-3 (Fig. 3.8E) into broiler diet had little effect on the presence of 
caspase-3 positive cells, compared to the control (Fig 3.8B).  
These results suggest that dietary inclusion of MRF-1 into broiler diet may reduce the levels of 



















3.2.6 Mannan-rich fraction supplementation resulted in a decrease in RIPK3 
expression levels  
 
 
      
  
 
             
             
        
 
Figure 3.9 Effect of mannan-rich fraction supplementation on RIPK3 protein expression 
levels 
Immunoblot analysis of RIPK3 in tissue lysates from control unsupplemented and mannan-
rich fraction supplemented broiler chickens on day 35. β-actin was used as a loading control. 
Each lane represents a separate biological replicate (n=3). Data for relative densitometry was 
relative to sample C2. (*, P < 0.05, **, P < 0.01).  Error bars, SEM. 
 
 
Control MRF-1 MRF-2 MRF-3 
IB : β-Actin 
    1                  2                 3               1        2                3                  1              2               3               1                2                3 
IB : RIPK3 
57kDa → 

























      
 
 
Figures 3.10 Effect of mannan-rich fraction supplementation on in situ necroptotic levels 
in broiler chickens at day 35. 
Broiler chickens were supplemented with control chow diets or supplemented with MRF-1, 
MRF-2, MRF-3. (A) Intestinal tissue was processed for RIPK3 staining with RIPK3positive 
cells indicated as % of cells that show positive RIPK3 staining. Representative images of 
RIPK3 staining of duodenal intestinal tissue from chickens fed on (B) Control diet, (C) MRF-
1, (D) MRF-2 and (E) MRF-3 are also shown. Data are presented as the mean +/- SEM from 5 
birds for caspase staining with four sections analysed per bird under 40x magnification. Brown 
staining (labelled) indicates RIPK3 staining.  Statistical significance between control and each 





















Given that mannan-rich fraction supplementation in broiler diets has been shown to potentially 
decrease apoptotic levels in intestinal tissue, it’s effect on RIPK3 (a marker of necroptosis) 
expression levels was next explored. Necroptosis is generally induced in response to a bacterial 
or viral infection (Pasparakis & Vandenabeele, 2015). Necroptotic cell death, a type of 
programmed necrotic cell death, is characterised by the activation of MLKL into phospho-
MLKL by RIPK3 (Kim and Pasparakis, 2014). The necroptotic marker RIPK3 was chosen for 
analysis due to the unavailability of phospho-MLKL antibodies reactive to chickens. RIPK3 
(in addition to MLKL) is present in both the cytoplasm and nucleus of the cell, playing a key 
role in the formation of the necrosome (Nogusa et al., 2016). Tissue lysates from each intestinal 
section were analysed for protein expression through western blot from a total of 3 birds per 
treatment. The incorporation of each dietary supplement led to a decrease in RIPK3 expression 
levels, and a significant decrease upon MRF-2 (Fig. 3.9) and MRF-3 (Fig. 3.9) dietary 
incorporation. 
To further characterise the effect of MRF supplementation on RIPK3 expression levels, it was 
necessary to assess its effect though immunohistochemical analysis. Immunohistochemical 
analysis was carried out on each intestinal segment on a total of 5 birds per treatment. 
Incorporation of MRF-1 (Fig. 3.10C) resulted in a significant decrease in RIPK3 levels in the 
duodenum, ileum and the caecum compared to the control (Fig. 3.10B). Dietary 
supplementation of MRF-2 (Fig. 3.10D) into broiler diet led to a significant decrease in RIPK3 
cells in the duodenum and the ileum. The inclusion of MRF-3 (Fig. 3.10E) into broiler diet 
resulted in a significant decrease in RIPK3 levels in the ileum and the caecum, with a slight 
decrease present in the duodenum and the jejunum.  
These results indicate that MRF incorporation into broiler diet may result in a decrease in 
RIPK3 expression levels in intestinal tissue. These results are consistent with the decrease in 
apoptotic levels observed in Section 3.2.5 




3.2.7 Mannan-rich fraction supplementation resulted in alterations in p-Akt 
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Figure 3.11 Effect of mannan-rich fraction supplementation on p-Akt protein expression 
levels 
Immunoblot analysis of p-Akt in tissue lysates from control unsupplemented and mannan-rich 
fraction supplemented broiler chickens on day 35. β-actin was used as a loading control. Each lane 
represents a separate biological replicate (n=3). Data for relative densitometry was relative to 
sample C2. (*, P < 0.05, **, P < 0.01).  Error bars, SEM. 
60kDa → 
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As a result of the observed decrease in RIPK3 expression levels upon MRF incorporation, the 
effect of MRF supplementation on p-Akt expression levels was next explored. Phospho-Akt is 
intrinsically linked to several signalling pathways with implications for cell survival, growth 
and inhibition of apoptosis through the inactivation of apoptosis-associated molecules such as 
Bad and c-Raf (McCubrey et al., 2007). Tissue lysates from each intestinal section were 
analysed for protein expression through western blot from a total of 3 birds per treatment. The 
addition of MRF-1 into broiler diet resulted in a negligible effect on p-Akt expression (Fig. 
3.11). Supplementation of MRF-2 led to a slight increase compared to the control while dietary 















3.2.8 Mannan-rich fraction supplementation had no effect on expression of 





























































































































































Figure 3.12 Effect of mannan-rich fraction supplementation on serum levels of pro- and anti-
inflammatory cytokines 
Serum cytokine analysis of control and mannan-rich fraction supplemented broiler chickens 
(n=12). Broiler chickens were sacrificed and serum analysed by ELISA for (a) IL-1β (b) IL-6 
(c) IL-10 (d) IL-12 and (e) IL-18. Data are presented as the mean +/- SEM from 12 birds. 
Statistical significance was determined using two-tailed Student’s t-test (*, p < 0.05). 
 




Given that the tissue morphological analyses suggested that MRF supplementation may 
improve tissue integrity and therefore enhance the ability of the GIT to prevent bacterial 
adhesion, the next step involved examining if MRF incorporation altered the expression levels 
of inflammatory cytokines in serum. Serum was collected from broiler chickens on day 35 and 
the expression levels of IL-1β (Fig. 3.12a), IL-6 (Fig. 3.12b), IL-10 (Fig. 3.12c), IL-12 (Fig. 
3.12d), and IL-18 (Fig. 3.12e) were assessed by ELISA. Analysis of IL-12 and IL-18 was 
carried out using a chicken IL-12 and chicken IL-18 ELISA kit (Abbexa) and was performed 
as per manufacturer’s instructions. Analysis of IL-1β, IL-6 and IL-10 was carried out using 
specialised kits from Elabscience and was performed as per manufacturer’s instructions. None 















3.2.9 Mannan-rich fraction supplementation alters inflammatory cytokine 
expression levels in intestinal tissue 
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Figure 3.13 Effect of mannan-rich fraction supplementation on intestinal expression of 
IL-1β  
Tissue lysate cytokine analysis of control and mannan-rich fraction supplemented broiler 
chickens in the (a) duodenum, (b) jejunum, (c) ileum and (d) caecum (n=10). Broiler chickens 
were sacrificed and tissue lysate analysed by ELISA for IL-1β expression. Data are presented 
as the mean +/- SEM from 10 birds. Statistical significance was determined using two-tailed 
Student’s t-test (*, p < 0.05).  
 
     




(a)  (b)  
      
(c)     (d)  
 
Figure 3.14 Effect of mannan-rich fraction supplementation on intestinal expression of 
IL-10  
Tissue lysate cytokine analysis of control and mannan-rich fraction supplemented broiler 
chickens in the (a) duodenum, (b) jejunum, (c) ileum and (d) caecum (n=10). Broiler chickens 
were sacrificed and tissue lysate analysed by ELISA for IL-10 expression. Data are presented 
as the mean +/- SEM from 10 birds. Statistical significance was determined using two-tailed 
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Figure 3.15 Effect of mannan-rich fraction supplementation on intestinal expression of 
IL-12  
Tissue lysate cytokine analysis of control and mannan-rich fraction supplemented broiler 
chickens in the (a) duodenum, (b) jejunum, (c) ileum and (d) caecum (n=10). Broiler chickens 
were sacrificed and tissue lysate analysed by ELISA for IL-12 expression. Data are presented 
as the mean +/- SEM from 10 birds. Statistical significance was determined using two-tailed 
Student’s t-test (*= p < 0.05, **= p<0.01).  
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Figure 3.16 Effect of mannan-rich fraction supplementation on intestinal expression of 
IL-18  
Tissue lysate cytokine analysis of control and mannan-rich fraction supplemented broiler 
chickens in the (a) duodenum, (b) jejunum, (c) ileum and (d) caecum (n=10). Broiler chickens 
were sacrificed and tissue lysate analysed by ELISA for IL-18 expression. Data are presented 
as the mean +/- SEM from 10 birds. Statistical significance was determined using two-tailed 











While the work in the previous section indicated that MRF dietary inclusion had little effect on 
serum inflammatory cytokine expression levels, the more localised role of MRF 
supplementation in controlling intestinal expression of inflammatory cytokines was next 
explored. Tissue lysates from broiler chickens (n=10) were assayed for the expression level of 
inflammatory cytokines IL-1β (Fig. 3.13), IL-10 (Fig. 3.14), IL-12 (Fig. 3.15) and IL-18 (Fig. 
3.16) in each intestinal section. The analysis for IL-1β and IL-10 was carried out using chicken 
ELISA kits from Elabscience as per manufacturer’s instructions. The analysis for IL-12 and 
IL-18 was carried out using chicken ELISA kits from Abbexa and as per manufacturer’s 
instructions. 
Incorporation of MRF-1 led to a slight increase in IL-1β expression in the jejunum (Fig. 3.13B) 
and a significant increase in expression in the ileum (Fig. 3.13C) compared to the control 
(Fig.3.13C). There was no change in IL-1β expression in the caecum (Fig. 3.13D). Dietary 
addition of MRF-2 resulted in a little change in IL-1β expression in duodenal (Fig. 3.13A) and 
jejunal (Fig. 3.13B) tissue, with a significant decrease observed in the caecum (Fig 3.13D). A 
slight increase in IL-1β expression was observed in the ileum (Fig. 3.13C). The expression 
levels of IL-1β upon MRF-3 dietary inclusion was negligible in each intestinal tissue (Fig. 
3.13A-D). 
Incorporation of MRF-1 led to a reduction in IL-10 (Fig. 3.14) expression in each intestinal 
tissue analysed with the exception of the ileum (Fig. 3.14C), however this did not reach 
statistical significance. The inclusion of MRF-2 into broiler diet resulted in a slight decrease in 
IL-10 expression in each intestinal tissue, with the exception of the ileum (Fig 3.14C). The 
expression levels of IL-10 upon MRF-3 dietary inclusion was decreased in the duodenum (Fig. 
3.14A), jejunum (Fig. 3.14B) and the ileum (Fig. 3.14C), however this did not reach statistical 
significance. The expression level of IL-10 was unchanged in the caecum (Fig. 3.14D). 




Incorporation of MRF-1 led to a slight increase in IL-12 expression in each intestinal tissue 
analysed (Fig. 3.15A-D) with the exception of the caecum (Fig. 3.15D), where a slight 
reduction was observed. Supplementation of broiler diet with MRF-2 resulted in a decrease in 
IL-12 expression in the duodenum (Fig. 3.15A) and ileum (Fig. 3.15C) compared to the control 
(Fig. 3.15C), however this did not reach statistical significance. There was a significant 
decrease in IL-12 expression levels in the caecum (Fig. 3.15D). The change in expression levels 
of IL-12 upon MRF-3 dietary inclusion was negligible in the duodenum (Fig. 3.15A), ileum 
(Fig. 3.15C) and the caecum (Fig. 3.15D). The expression level of IL-12 was unchanged in the 
jejunum (Fig. 3.15B), upon MRF-3 incorporation. 
Dietary incorporation of broiler diet with MRF-1 led to a consistent decrease in IL-18 
expression in each intestinal tissue analysed (Fig. 3.16A-D). The inclusion of MRF-2 resulted 
in a decrease in IL-18 expression, with a significant decrease in expression levels in the caecum 
(Fig 3.18D). The alteration of IL-18 expression upon MRF-3 dietary incorporation was 
negligible in the jejunum (Fig. 3.18B). The expression level of IL-18 was decreased in the 
duodenum (Fig. 3.18A) and ileum (Fig. 3.18C). MRF-3 addition into broiler diet led to an 
increase in IL-18 expression in the caecum (Fig. 3.18D). 
These results suggest that MRF incorporation into broiler diets may alter the expression levels 
of inflammatory cytokines in tissue lysates. MRF inclusion has been shown to generally 
increase IL-1β expression levels in this study, which is consistent with previous findings 
incorporating alternative mannan-rich fractions (Lamkanfi et al., 2009; Saegusa et al., 2009). 
IL-1β and IL-18 are closely linked to the NLRP3 inflammasome in mammals (Kesavardhana 
and Kanneganti, 2017). This association is not yet well defined in avian immunology. In 
mammals, the activation of caspase-1 leads to the upregulation of both IL-1β and IL-18 
however in avians, pro- IL-1β does not contain a cleavage site for caspase-1 (Ye et al., 2015). 
This may suggest an alternative activation mechanism for pro- IL1β activation and perhaps an 




alternative mode of action. Further research is necessary to fully elucidate the mechanism of 
pro- IL-1β processing. The role of IL-18 in immunology remains heavily debated. Increased 
IL-18 expression had initially been associated with enhanced epithelial layer integrity and 
cellular proliferation (Dupaul-Chicoine et al., 2010; Zaki et al., 2010). Recent evidence has 
suggested a link between increased IL-18 expression levels and disease progression in addition 
to dysregulation of the mucosal barrier (Nowarski et al., 2015). Nowarski et al. (2015), have 
also reported that increased IL-18 expression may lead to the inhibition of goblet cell 
formation, therefore resulting in a decreased mucus layer thickness. The results observed for 
MRF incorporation on IL-18 expression are consistent with this finding, as are the results for 
mucus layer thickness and goblet cell density in Section 3.2.1.  
The above results suggest an effect of MRF supplementation on inflammatory cytokine 
expression levels, however the consequences of these alterations remain somewhat unclear.   
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The poultry industry is one of the most rapidly expanding sectors worldwide (GLEAM 2). 
Almost 100 million tonnes of poultry meat is produced globally each year to meet the demands 
of a continually-growing population (Mottet and Tempio, 2017). With the ever-increasing 
expansion of the poultry industry and poultry meat production, the development of effective 
dietary supplements is of critical importance. Advances in the formulation and development of 
naturally-derived dietary supplements has been brought into sharp focus as a result of the ban 
on antibiotic growth promoters (AGPs) (Verraes et al., 2013). The ban on AGP dietary 
incorporation into animal feed resulted initially in an increase in disease incidence and animal 
mortality rates (Schlundt and Aarestrup, 2017). The increased disease incidence and mortality 
rates led to much-improved efforts to develop effective natural feed additives. Investigations 
into the efficacy of natural feed additives initially focussed primarily on observed differences 
on bird weight gain and feed-conversion ratios (Corrigan et al., 2017; Demir et al., 2005; 
Taylor et al., 2003; Wood et al., 1996). Furthermore, these studies demonstrated that an 
increased weight gain and an improved broiler performance could be obtained upon natural 
feed dietary supplementation. Recently, studies determining the effect of natural feed additives 
in animal diets have progressed to examine the effects of supplementation on animal health 
through analysis of various markers of intestinal health and function (Kiczorowska et al., 2017; 
Lillehoj and Lee, 2012). The majority of markers employed for intestinal health and function 
analysis consist of components of the innate immune system and mucosal integrity 
(Kiczorowska et al., 2017; Niewold, 2007). These components may include cell death markers, 
inflammatory cytokine expression levels in addition to the enumeration of goblet cell presence. 
The structure and integrity of the mucosal layer is critically important for optimal nutrient 
absorption in addition to host defence from pathogenic invasion and adhesion (Petersson et al., 
2011). Dysregulation of the mucus layer has been associated with impaired nutrient transport 
and increased pathogenic adhesion (Cornick et al., 2015). MRF-containing supplements 




derived from the cell wall of Saccharomyces cerevisiae may confer the host with an enhanced 
innate response and improved intestinal function. For this reason, investigations of the effects 
of mannan-rich fraction dietary inclusion into broiler diet are of vital importance for elucidating 
the potential benefits of MRF incorporation on broiler intestinal health and immunity. 
While the inclusion of mannan-rich fractions has been postulated to affect broiler intestinal 
health (Corrigan et al., 2017), the work presented in this thesis demonstrates the potential role 
mannan-rich fractions may have on broiler digestive enzyme capacity, tissue morphology, 
serum and tissue lysate inflammatory cytokine expression, cell death and the protein expression 
levels of signalling components. In order to achieve this, a trial involving 492 male broiler 
chickens was carried out. Broilers were split randomly into 4 groups and fed either a basal diet 
or a basal diet including a mannan-rich fraction supplement. On day 35, serum and tissue 
samples were obtained, processed, and stored for future analyses.  
The majority of nutrient absorption occurs in the small intestine, primarily in the villi (Clevers, 
2013). The height and surface area of villi was demonstrated to increase upon mannan-rich 
fraction incorporation into broiler diet. The increase in VH and VSA may in theory increase 
the surface area available for nutrient absorption, thereby improving villus development and 
general global gut health. This observation is in agreement with the increased digestive enzyme 
capacity observed upon mannan-rich fraction supplementation. Previous studies into the effect 
of MRFs on broiler health have shown an increase in bird weight gain on day 35, compared to 
a control (Corrigan et al., 2017). Crypt depth was also shown to increase upon MRF 
incorporation, whereas previous reports (analysing different products) on the effect of dietary 
additives have suggested otherwise (Luo et al., 2015; Xiao et al., 2012). The observed increase 
in crypt depth in this trial may be a result of increased enterocyte migration to the villus to 
account for the enhanced villus surface area and corresponding increase in digestive enzyme 




capacity. In addition, the decrease in the thickness of the muscularis mucosae may potentially 
aid in the passage of nutrients into systemic circulation (Cheng et al., 2010). These findings 
provide strong evidence that the increases in VH, VSA and the decrease in muscularis mucosae 
thickness may point towards a role of MRF incorporation in potentially improving nutrient 
availability and absorption. Such findings are consistent with previous reports detailing the 
effects of naturally-derived dietary additives into cattle and piglets (Jiang et al., 2015; Zitnan 
et al., 2008). Enhanced nutrient availability and absorption would in theory result in an 
enhanced bird weight gain and improved gastrointestinal integrity.  
 
Another essential function of the gastrointestinal system is protection from invading pathogens 
and bacterium (Cheng et al., 2010). This role is served by the presence of mucins, which form 
a mucus layer that prevents the invasion and adhesion of foreign pathogens (Cornick et al., 
2015). The observed increase in alkaline phosphatase enzyme capacity indicates towards an 
increased protection upon MRF incorporation. Goblet cell density and mucus layer thickness 
were examined in order to further delineate the potential role of mannan-rich fraction 
supplementation in broiler intestinal immunity. The evidence provided here proposes that MRF 
incorporation may result in an increased goblet cell density and mucus layer thickness. Goblet 
cells secrete mucins, which are the constituent component of the mucus layer. This mucus layer 
provides a protective barrier between the external environment and epithelial cell surface 
(Johansson et al., 2013). Goblet cells also interact with resident gut microbiota to maintain 
barrier function (J. R. Kelly et al., 2015). The composition of gut microbiota in the intestine 
has been demonstrated to adjust in response to stress or infection, possibly leading to increased 
inflammation (Jang et al., 2017). This is a very interesting concept in light of the fact that 
breakdowns in tissue barrier integrity has been previously reported to result in malabsorption 
of available nutrients (Awad et al., 2017). An increased mucus layer thickness potentially 




provides enhanced protection from invading pathogens and would, crucially, therefore permit 
the increased volume of nutrients to be utilised for growth rather than for the repair of damaged 
tissues as a result of pathogenic invasion. Further investigations into the interplay between the 
protection offered from the mucus layer from pathogen adhesion and the utilisation of available 
nutrients towards productive processes may deepen our understanding of the benefits of 
improved tissue morphology.  
 
The results of a trial that formed the basis for this study (Corrigan et al., 2017) demonstrated 
that MRF incorporation into broiler diet led to an increased weight gain, when compared to a 
control. The work presented in this study establishes that the incorporation of MRF-1 and 
MRF-2 into broiler diet results in enhanced digestive enzyme capacity. Increases in the 
capacity of digestive enzymes maltase and sucrase may in theory increase the ability of the 
host to intake a greater volume of nutrients. This is intriguing as an increased rate of nutrient 
absorption may lead to correlated improvements in tissue integrity and bird weight gain. This 
result may in theory explain the demonstrated increase in weight gain and feed conversion 
ratios observed in the Corrigan et al., trial. Furthermore, the capacity of enzyme alkaline 
phosphatase was also determined to be augmented upon MRF-1 and MRF-2 incorporation. 
Alkaline phosphatase serves as an essential defence mechanism of the gastrointestinal tract, 
with roles including the prevention of pathogen translocation into systemic circulation (Bilski 
et al., 2017). It could be speculated that the increases in disaccharide enzyme capacity and 
alkaline phosphatase capacity indicate that the supplementation of mannan-rich fractions may 
result in an increased ability to intake a greater volume of nutrients in addition to increased 
protection from pathogenic invasion.  
Cellular death is a hallmark of inflammation (Yang et al., 2015). Several types of cell death 
exist, such as apoptosis (considered to be immunologically silent), necroptosis (an 




inflammatory form of cell death) and pyroptosis (a highly inflammatory form of cell death) 
(Sharma and Kanneganti, 2016). Enhanced cellular death levels may be the result of the onset 
of inflammation (Yang et al., 2015). Several markers exist for identifying the type of cell death 
occurring. TUNEL staining and caspase-3 are considered markers for apoptotic cell death while 
RIPK3 has been implicated as an essential component of necroptotic cell death (Zhu et al., 
2016). Incorporation of MRF-1 led to a significant decrease in TUNEL-positive staining in the 
duodenum and jejunum and little effect in the ileum and caecum. However, the effect of MRF-
2 and MRF-3 incorporation was less pronounced. There was generally a slight decrease in 
caspase-3 positive cells upon mannan-rich fraction incorporation. It was intriguing that the 
effects of mannan-rich fraction dietary inclusion appeared to lessen somewhat towards the 
large intestine when compared to the effects observed in the duodenum and jejunum. 
Interestingly, there was a notable decrease in RIPK3 cells upon dietary supplementation. This 
effect was most pronounced upon MRF-1 dietary inclusion. It could be speculated that the 
increases in mucus layer thickness (as a direct result of the enhanced goblet cell density) and 
alkaline phosphatase enzyme capacity are playing a critical part in the observed increased 
broiler intestinal health.  
 
The data presented in this thesis suggests a role of MRF incorporation resulting in decreased 
cellular death levels in broilers. This potential role was further explored through analysis of p-
Akt and RIPK3 protein expression levels in duodenal tissue. Phospho-Akt is implicated in 
several cellular pathways involving apoptosis, cellular proliferation and cellular differentiation 
(Hart and Vogt, 2011). Western blot analysis of p-Akt expression revealed a significant 
increase in expression upon MRF-3 incorporation into broiler diet. Interestingly, incorporation 
of MRF-2 and MRF-3 also led to a significant reduction in RIPK3 protein expression levels. 
This finding was consistent with the immunohistochemical analysis of RIPK3 in Section 3.2.6. 




RIPK3 is a necroptotic cell death marker, a highly inflammatory form of cell death (Nogusa et 
al., 2016). Interestingly, knockdown of RIPK3 in mice has been demonstrated to induce a 
switch from TNF-mediated necroptosis to a kinase-dependant apoptotic form of cell death 
(Remijsen et al., 2014). As apoptosis is an immunologically silent process, the effect of RIPK3 
knockdown on intestinal inflammation would be an interesting avenue to explore. Increased p-
Akt expression has been linked to the inhibition of apoptosis (Granado-Serrano et al., 2006; 
Hart and Vogt, 2011). The findings illustrated here can be linked to the decreased expression 
of apoptotic cell markers in Section 3.2.5. Similarly, the decrease in expression of apoptotic 
cell markers can potentially be attributed to the enhanced mucus layer thickness and increased 
alkaline phosphatase enzyme capacity. The ratio of cellular death through processes such as 
apoptosis and the formation of new intestinal cells are essential towards preserving intestinal 
homeostasis. The maintenance of homeostasis is a critical factor in barrier function in the 
intestine (Williams et al., 2015). Recent evidence has suggested that regulated levels of 
apoptosis convey no effect on the function of the epithelial barrier, however increased levels 
of apoptosis- as a result of intestinal infection or inflammation- can contribute to intestinal 
barrier dysfunction (through the loss of epithelial tight junction proteins) and increased 
permeability (Demehri et al., 2013). The results from this trial are in agreement with the study 
by Demehri et al., as MRF incorporation has been demonstrated to result in a reduction in 
apoptotic markers and an improvement in intestinal morphometric features.  
 
The onset of inflammation can be characterised by alterations in the expression of a range of 
inflammatory cytokines, primarily IL-18, IL-12 and IL-1β (Netea et al., 2016). However, MRF 
incorporation into broiler diet had no effect on the expression levels of inflammatory cytokines 
in serum. The expression of IL-10 was not significantly altered in tissue lysates upon mannan-
rich fraction incorporation. There was a significant decrease in IL-12 expression upon MRF-2 




incorporation in the caecum. Furthermore, IL-1β expression was significantly increased in the 
ileum upon MRF-1 incorporation and significantly decreased in the caecum upon MRF-2 
supplementation. Interestingly, IL-18 expression was almost consistently decreased upon 
dietary incorporation of each mannan-rich fraction. This divergent finding between IL-1β and 
IL-18 warrants further investigation. IL-1β and IL-18 are considered to be closely linked due 
to their dual activation upon inflammasome assembly (Kesavardhana and Kanneganti, 2017). 
The slightly diverging results presented in this thesis may be as a result of alternative activation 
mechanisms or mode of action in avians as compared to mammals. This deficit in our 
understanding of IL-1β/IL-18 in inflammasome activation in avian species requires further 
attention to elucidate their potential role in inflammatory diseases. The exact implication of 
increased IL-18 expression is subject to renewed discussion (Dupaul-Chicoine et al., 2010; 
Nowarski et al., 2015; Siegmund, 2010). Recent evidence has pointed towards increased IL-18 
expression driving disease progression (Nowarski et al., 2015; Vanden Berghe et al., 2014). 
Nowarski et al., (2015) demonstrated that deletion of IL-18 and its receptor conferred host 
protection in a colitis mouse model. It was also demonstrated that increased IL-18 expression 
resulted in a reduction of goblet cell maturation. The data presented in this thesis illustrate that 
dietary incorporation of mannan-rich fractions results in a consistent decrease in IL-18 
expression. This finding may be explained somewhat by the increased mucus layer thickness 
and improved tissue integrity, conferring greater protection to the host as a result of dietary 
supplementation.  
 
In conclusion, this study has described the effect of MRF incorporation into broiler diet on 
intestinal health and immunity. The role of MRF inclusion in enhancing digestive enzyme 
capacity was elucidated, with overall implications for bird weight gain. Histological analyses 
of intestinal tissue upon MRF supplementation demonstrated an improved tissue architecture, 




compared with the control. Increases in VH and VSA may lead to an enhanced surface area 
available for nutrient absorption and assimilation whilst a higher density of mucin-secreting 
goblet cells may confer a greater protection to the host from pathogenic invasion and 
subsequent induction of inflammation through enhanced barrier function. The role of MRF 
incorporation in reducing the expression of RIPK3, a marker of the necroptotic cell death 
process, was also highlighted. The incorporation of mannan-rich fractions into broiler diet has 
been demonstrated to potentially increase bird weight gain through enhanced digestive enzyme 
capacity and confer greater protection from invading microorganisms as a result of improved 
barrier function and tissue morphology. Future work will be required to further elucidate the 
role of IL-1β/IL-18 activation in inflammasome assembly and ultimately inflammatory disease 
progression. Further understanding of the avian immune system and the interplay of 
Campylobacter-specific TLRs such as TLR4 and TLR21 (the avian equivalent of mammalian 
TLR9) will tie in with this work to provide a clearer portrait of the underlying mechanisms of 
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